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Abstract
The Smyth line (SL) of chickens is a well-established animal model for the study of
spontaneous autoimmune vitiligo, displaying all the characteristics of human vitiligo. In
humans, phenolic derivative 4-tertiary butyl phenol (4-TBP) has been shown to trigger
vitiligo in susceptible individuals. In vitiligo-prone SL-chickens, live turkey herpesvirus
(HVT) infection at hatch was identified as the most effective trigger of SL-vitiligo
expression. This dissertation examined the role of the environmental factors 4-TBP and
HVT in the etiology of SL-vitiligo. Specifically, the generation of reactive-oxygen-species
by melanocyte-containing feather tissue (MC-FT) and cultured melanocytes in response to
4-TBP exposure in vitro (Study I) was examined. In vivo leukocyte infiltration,
morphology of melanocytes, and gene-expression post 4-TBP injection into the feather
pulp were also monitored (Study II). Results showed that independent of HVT
administration at hatch and age of chicken, in vitro 4-TBP exposure induced more
oxidative stress (P < 0.05) in cultured MC-FT and melanocytes from SL- than
control-chickens. Alterations in melanocyte morphology and gene-expression of
melanogenesis-, apoptosis- and stress-related proteins were observed in in vivo
4-TBP-treated SL compared to control feathers. These data support a heightened
sensitivity of melanocytes to 4-TBP in SL-chickens. The reduction in MITF and increase in
HSP70 and BCL2 observed in control- but not in SL-feathers may be an effective
protective response to 4-TBP-induced cellular stress. In Study III, the relationship between
HVT and SL-vitiligo expression was further examined. The observed progressive

reduction (90 to 0%) in HVT’s ability to trigger SL-vitiligo during the first 10 weeks of age
suggests that HVT exerts its effect on vitiligo expression when adaptive immunity is not
fully developed. The observation of elevated cytokine expression (IL-8, IL-10, IFN-γ and
IL-21) during active SL-vitiligo which was preceded by increased levels of HVT at 1 to 0.5
weeks before SL-vitiligo onset, strengthens the association of HVT-infection and
development of the melanocyte-specific autoimmune response. With the translocation of
HVT to the feather, its presence and resulting immune activity may cause cellular stress in
the inherently defective SL-melanocyte. Stress-associated melanocyte alterations may lead
to immune recognition of SL-melanocytes and development of melanocyte-specific
autoimmune disease.
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INTRODUCTION

Vitiligo is an acquired autoimmune disease in human patients characterized by loss of
functioning melanocytes in affected areas of the skin. In order to understand the initial
etiological and pathogenic mechanisms of vitiligo, appropriate animal models are crucial
to determine the processes involved in the development of this disorder. The value of the
Smyth line (SL) chicken as an animal model for human vitiligo is supported by many
phenotypical and etiological similarities between human vitiligo and SL vitiligo (SLV)
(Literature Review). Like human vitiligo, the spontaneous development of SLV is the
result of complicated processes involving the interaction of genetic, immunological,
metabolic and environmental factors in susceptible individuals.

Like human vitiligo, there is an inherent susceptibility for vitiligo in SL chickens
which is partially manifested by intrinsic melanocyte abnormalities. Melanocytes from SL
chickens that never developed vitiligo and from SLV chickens prior to the onset of feather
amelanosis appear to be normal when examined by light-microscopy. However,
abnormally-shaped melanosomes could be observed in SL melanocytes using transmission
electron microscopy. These altered melanosomes were not observed in melanocytes from
the parental Brown line (BL) control (Boissy et al., 1983). Cultured embryo-derived
melanocytes from SL chickens also exhibited abnormalities such as fewer dendrites and
selective autophagocytosis of melanosomes compared to cultured melanocytes from BL
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and Light Brown Leghorn (LBL) controls (Boissy et al., 1986). Together, these
observations support the presence of inherent melanocyte defects in SL chickens.

As shown through immunosuppression studies, the inherent melanocyte defect alone
is not sufficient for SLV expression without a functioning immune system, but appears to
play a role in activating a melanocyte-specific autoimmune response (Smyth et al., 1981).
Several studies have provided evidence supporting the role of the immune system in the
pathology of SLV. A possible role of humoral immunity was demonstrated by the presence
of autoantibodies in SLV chickens several weeks before visible onset of SLV that were
capable of binding to melanocyte-specific proteins (Austin et al., 1992; Austin and Boissy,
1995). Roles of inflammation and cell-mediated immunity in melanocyte loss were
suggested by the observation of elevated levels of circulating inflammatory cells just prior
to and at visible onset of SLV. Moreover, SLV development was associated with the
infiltration of macrophages and lymphocytes into the target tissue, specifically the pulp and
melanocyte-containing barb ridge of growing SL feathers. Prior to visible onset of SLV,
infiltration consisted primarily of T helper cells (CD4+); whereas, cytotoxic (CD8+)
lymphocytes predominated at visible onset of vitiligo and during active melanocyte
destruction (Erf et al., 2001; Erf et al., 1995; Shresta et al., 1997). The presence of CD8+
cells was related to melanocyte apoptosis in the growing feather from SLV chickens (Wang
and Erf, 2003, 2004), supporting a role of cytotoxic T cells in melanocyte loss.
Additionally, feather-infiltrating lymphocytes also included a significant proportion of
2

IgM+ B cells (Shresta et al., 1997; Shi and Erf, 2012). Recent gene expression analysis of
feather tissues collected prior to and near onset of SLV using quantitative reverse
transcriptase polymerase chain reaction (qRT-PCR) showed that active SLV was
accompanied by high expression of pro-inflammatory cytokines interleukin (IL)-1β, IL-8,
IL-12, IL-21 and interferon (IFN)-γ, but low expression levels of IL-4. These findings
further support the presence of cellular, Th1-mediated immune activity directed against
melanocytes in SLV chickens (Shi and Erf, 2012). Therefore, anti-melanocyte
cell-mediated immunity appears to play a crucial role in melanocyte loss in SLV.

In addition to intrinsic melanocyte defects and autoimmune components involved
in SLV development, expression of vitiligo in susceptible SL chickens appears to require
environmental triggers. Routine administration of live herpesvirus of turkey (HVT) at
hatch to protect chicks from infection with Marek’s disease virus was revealed as one
environmental factor that is highly associated with vitiligo expression in susceptible SL
chickens (Erf et al., 2001).

As shown by Manga et al. (2006), skin exposure to phenolic derivatives, such as
4-tertiary butyl phenol (4-TBP) can trigger vitiligo in susceptible individuals by inducing
oxidative stress that is more readily overcome by melanocytes from normally pigmented
individuals than from individuals with vitiligo. The oxidation of 4-TBP by tyrosinase
(TYR) to quinones (Thörneby-Andersson et al., 2000), causes futile redox cycling and
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oxygen activation forms cytotoxic levels of hydrogen peroxide and glutathione disulfide
(GSSG), thereby induces oxidative stress (O'Brien, 1992). In SL vitiligo a disturbed redox
state in the target tissue was also reported, including increased levels of reactive oxygen
species (ROS) generation in feather samples from SL chickens compared to BL and LBL
chickens (Lockhart, 2004). Additionally, feather samples from SLV chickens were found
to have decreased anti-oxidative capacity as well as increased levels of lipid peroxidation
compared to BL and LBL controls (Erf et al., 2005; Wijesekera, 2004). Oxidative stress
has been shown to play a role in triggering various clinical disorders. The exact role of
oxidative stress in vitiligo is unclear, but it is assumed to play a part in either the
development of the disorder or the progressive loss of melanocytes.

Taken together, the SL autoimmune vitiligo model provides excellent opportunities
to study the complex interactions of factors in this multifactorial polygenic disorder
which give rise to autoimmune destruction of intrinsically abnormal melanocytes under
favorable conditions.

Based on previous studies, we hypothesized that the effect of 4-TBP in SL chickens
will be consistent with 4-TBP’s effects as a trigger of human vitiligo in susceptible
individuals. By using the SL chicken model for human vitiligo, in vitro and in vivo effects
of 4-TBP in melanocytes/melanocyte-containing tissue can be examined. Specifically,
examination of 4-TBP’s effect on ROS production and gene expression profiles of proteins
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related to melanogenesis, apoptosis and stress in SL and controls chickens will provide
insight into the mechanisms underlying the phenotypical abnormalities in melanocytes
from SL chickens. Additionally, we also hypothesized that determination of cytokine
involvement in the initiation of the melanocyte-specific autoimmune response together
with assessment of herpesvirus of turkey (HVT) viral load in the target tissue will provide
insight into the interplay of genetic susceptibility, immune system activities and
environmental factors in the spontaneous expression of SL vitiligo. In summary, this
dissertation will provide important new information regarding the complicated nature of
this disease and indicate new pathological components in this disorder.

Based on the availability of the chicken genome sequence and limited availability of
antibodies to chickens proteins (Burt, 2004), qRT-PCR has become the main approach used
to examine gene expression of various targets in this project. The objectives and
approaches of the current study were as follows:

Objective 1: To examine the effects of in vitro 4-TBP exposure of
melanocyte-containing feather tissue and feather- and embryo-derived melanocyte cultures
on oxidative stress and stress-, melanocyte-function and apopotosis-related gene
expression. For this purpose, pigmented growing feathers were collected from 1-, 4-, 7and 12-week-old SL, BL and LBL chickens that did or did not receive HVT. The newest
three millimeters growth (the melanocyte-containing, active pigmentation site) of the
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feathers was cultured with 4-TBP and the production of oxidative radicals was monitored
in vitro. Additionally, the ROS generation and morphological changes of both feather- and
embryo-derived melanocytes from SL and BL chickens were also monitored following
exposure to 4-TBP. qRT-PCR was used to determine relative expression of genes for
melanogenic proteins including tyrosinase (TYR), tyrosinase-related protein (TRP) 1 and 2,
microphthalmia-associated transcription factor (MITF), genes for anti-apoptotic proteins
B-cell lymphoma 2 (BCL2) and pro-apoptotic BCL2 homologous antagonist/killer-1
(BAK1), and the gene for heat shock protein (HSP)70.

Objective 2: To examine and monitor effects of 4-TBP on melanocyte morphology
and gene-expression in vivo. For this study, mononuclear infiltration, morphological
changes of melanocytes and gene expression related to melanogenesis and apoptosis, as
well as HSP70 was monitored post-4-TBP injection in vivo. Specifically, pigmented
growing feathers were collected before (0 h) and at 1, 3.5, 6 h, and 3 d after 10 µL of 4-TBP
(0.15 mg/mL) were injected into the pulp of growing feathers of 8-week-old SL, BL and
LBL chickens. The expression of genes TYR, TRP1, TRP2, MITF, BCL2, BAK1 and
HSP70 were examined using qRT-PCR in melanocytes from SL, BL and LBL chickens
upon 4-TBP treatment in vivo.

Objective 3: To determine the role of HVT in the development of SLV. SL and
control chickens were used in this study to determine: 1) the ability of HVT to induce SLV

6

expression at different ages; 2) primary and recall responses to HVT; and, 3) the
association between HVT viral load and cytokine production in the target tissue during
SLV development and progression. Specifically, the effect of HVT on the SLV incidence
was monitored by HVT vaccination of SL chicks at hatch or at 2-, 4-, 6-, 10-, 14-, and
18-weeks of age. Moreover, the primary and secondary response to HVT was evaluated
over a 10 day period based on leukocytes infiltration in the feather pulp in response to HVT
injection. To examine HVT viral load and cytokines gene expression throughout SLV
development, several approaches were used: HVT load (qPCR) and HVT gp expression
(qRT-PCR) was examined in spleen and feathers at various times post-HVT administration;
the location of HVT within the feather tissue was examined using laser capture
microdissection and qPCR; HVT levels and cytokine expression in feather samples
collected prior to and throughout SLV development were examined by qPCR and
qRT-PCR, respectively.

Results from this dissertation research provide new insights into the inherent
susceptibility of SL melanocytes, the role of environmental factors, and the immune
system responses involved in autoimmune loss of SL melanocytes. Furthermore, new
insight gained into the complicated etiology of vitiligo in SL chickens will drive the
direction of future research in SL and human vitiligo.
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CHAPTER I
LITERATURE REVIEW
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LITERATURE REVIEW

Human vitiligo

Vitiligo is an acquired idiopathic dermatological disorder characterized by postnatal
loss of epidermal pigment-producing cells (melanocytes) resulting in the formation of
white areas of skin. Vitiligo is presumed to affect approximately 1 % of the population in
the United States and 0.1 - 2 % worldwide (Moretti et al., 2006), irrespective of age, race,
ethnic origin or skin color. Human vitiligo can develop at any age, usually beginning in
childhood or young adulthood, with onset of pigmentation loss in the skin typically
occurring in individuals between 10 - 30 years of age (Tonsi, 2004). Approximately 20 %
of vitiligo patients have at least one first-degree relative with vitiligo and the risk of vitiligo
for immediate family members of vitiligo patients increases by 7 to 10 fold (Wolff et al.,
2007).

Vitiligo is commonly classified as segmental (asymmetrical distribution of white
patches) and nonsegmental (symmetrical distribution of white patches). The appearance of
irregularly-shaped white patches is the main symptom of vitiligo. These white patches pose
more than aesthetic problems and they have a major impact on the quality of life of the
patients. Physiologically, affected skins are more photosensitive than normal skin,
resulting in redness and damage from sun exposure. Additionally, vitiligo patients are more
prone to developing skin cancer and/or various autoimmune diseases (Nordlund and Lerner,
11

1982). Mentally, vitiligo patients tend to experience serious emotional stress, lack of
confidence on social contacts, and self-humiliation. Moreover, these physiological and
mental disorders interact and enhance each other (Salas-Alanis et al., 2011).

Clinical manifestations

Vitiligo is a hypopigmentation disorder where the loss of functioning melanocytes
causes the appearance of white patches on the skin. It commonly manifests itself in one to
several amelanotic white macules surrounded by a normal or hyperpigmented border
(Wolff et al., 2007). Sometimes the patches may have a red inflammatory border.

The lesions usually enlarge at an unpredictable rate and can appear on any part of the
body. The most frequent initial sites are hands, forearms, and feet; however, the most
commonly affected sites are the face, upper part of the chest, and dorsal aspect of the hands
(Tonsi, 2004).

Classification

There are different points of view on the classification of vitiligo. From one point of
view, vitiligo is classified as segmental, acrofacial, generalized and universal, based on the
pattern of involvement as focal, mixed and mucosal types (Wolff et al., 2007). The
generalized pattern is the most common one. Another point of view classifies vitiligo based
on the extension and distribution of lesions, delineating three types of vitiligo: localized,
12

generalized and universal vitiligo (Nordlund and Lerner, 1982). Currently, vitiligo is
classified into two major subtypes: segmental vitiligo (Type B) and non-segmental vitiligo
(Type A) (Le Poole et al., 1993; Koga et al., 1988). Type A is more common and frequently
associated with autoimmune disease and the Koebner phenomenon (skin lesions appearing
on lines of trauma resulting from either a linear exposure or irritation). Type B is rare and
includes focal lesions restricted to a segment of the integument. It usually exhibits a stable
course after a rapid onset and evolution (Torello et al., 2008).

Etiology and pathogenesis

Although the etiopathology of vitiligo is still not clearly understood, it has been well
established that vitiligo is a multifactorial disorder, involving both genetic and non-genetic
factors (Alkhateeb et al., 2003).

The genetics of vitiligo cannot be simply explained by Mendelian genetics (Alkhateeb
et al., 2003) and has been characterized by incomplete penetrance, multiple susceptibility
loci, polygenic traits and genetic heterogeneity. Vitiligo susceptible genes play a role in all
aspects of vitiligo pathogenesis and respond to environmental inputs hence genetics cannot
be considered as a separate phenomenon. Several facts have indicated that genetic factors
play an important role in the susceptibility to vitiligo. To begin with, statistics have shown
that 15 - 20 % of patients with vitiligo have one or more affected first-degree relatives,
which is higher incidence than the sporadic incidence of less than 2 % in the population
13

(Moretti et al., 2006). Similarly, the risk of vitiligo in a patient’s sibling among Caucasians
is approximately 6.1 % (Alkhateeb et al., 2003), which is a 16-fold increase compared to
the general Caucasian population where the prevalence of the disease is 0.38 % (Howitz et
al., 1977). Additionally, the concordance of vitiligo in monozygotic twins is 23 % which is
60-fold greater than that in the general population and 4-fold higher than that for a patient’s
sibling (Alkhateeb et al., 2003).

Currently, several vitiligo susceptibility genes have been identified, including
forkhead box D3 (FOXD3), human leukocyte antigen (HLA), PTPN22, NALP1 and
cytotoxic T lymphocyte antigen 4 (CTLA4). The majority of these genes are associated
with autoimmune susceptibility (Spritz, 2008; Boissy and Spritz, 2009). Specifically,
FOXD3 encodes a forkhead transcription factor that is a primary regulator of melanoblast
differentiation. Mutations of FOXD3 were co-segregated with vitiligo in the study of a
single family (Alkhateeb et al., 2005). Additionally, a strong association between
HLA-DR4 and vitiligo was illustrated in several populations including American
Caucasian, American African and Dutch (Foley et al., 1983; Dunston and Halder, 1990;
Venneker et al., 1993). Recently, allelic variations in the R620W region of the PTPN22
gene that encodes a lymphoid protein tyrosine phosphatase involved in T cell signaling
were associated with vitiligo susceptibility (Jin et al., 2010). Jin et al. (2007) also
demonstrated that allelic variants in the NALP1 gene, which encodes a key regulator of
innate immunity, increase the risk of vitiligo in Romanian populations. NALP1 protein is a
14

component of the inflammasome, a cytoplasmic multiprotein complex which mediates the
maturation of proinflammatory cytokines such as interleukin (IL)-1 and -18, and stimulates
cellular apoptosis. This gene and its activation could be involved in causing melanocyte
destruction and thereby vitiligo (Boissy and Nordlund, 2011). Lastly, the variations in the
CTLA-4 gene may be associated with secondary disorders such as autoimmune thyroid
disease (Spritz, 2010).

Among vitiligo researchers it is generally agreed that there is an inherent susceptibility
in certain individuals that together with environmental triggers leads to immune
system-mediated loss of melanocytes. In addition to the melanocyte-specific autoimmune
hypothesis, different hypotheses have been derived to explain the loss of melanocytes in
vitiligo, including the autocytotoxic hypothesis and the neural hypothesis. Each of these
hypotheses may play a role independently or in combination with the autoimmune
hypothesis in the development and progression of human vitiligo (Alikhan et al., 2011).

The autocytotoxic theory postulates that the accumulation of cytotoxic precursors
causes cell death. Specifically, by-products of melanin synthesis, such as phenolic radicals
or intermediates, may damage the pigment cell, and melanin synthesis in melanocytes
(Lerner, 1971). Either overproduction or inability to neutralize these byproducts of
melanogenesis contributes to the build-up of cytotoxic intermediates. Melanocytes are
genetically equipped with protective mechanisms to eliminate the toxic products
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associated with melanogenesis. It has been postulated that these protective mechanisms are
deficient in vitiligo patients (Lerner, 1971; Hann and Chun, 2000).

The neural hypothesis of vitiligo is based on observations of segmental vitiligo. It
suggests that a neurochemical agent is responsible for the melanocyte death in vitiligo
patients. Nerve endings release norepinephrine and other neural chemicals which may be
toxic to the melanocytes and their environment. It has been shown that vitiligo-negative
patients who experienced thoracoscopic sympathectomy (a surgical procedure where
certain portions of the sympathetic nerve trunk are destroyed) developed depigmentation in
the areas with disrupted sympathetic innervations (Westphal et al., 2009). Recently, it has
been shown that Schwann cells are derived from the same multipotent population of neural
crest cells as melanocytes. These bilaterally symmetrical characteristics, which relate to
innervations pattern, make it possible to hypothesize a new perspective regarding the role
of the nervous system in pigmentation and the precursor origin of Schwann cells (Igor and
Francois, 2010). This hypothesis may be suited to describe the symmetrical distribution
and abnormal sweating with segmental vitiligo (Nordlund and Lerner, 1982). However, it
is difficult to provide a complete picture of vitiligo development through the neural
hypothesis alone.

Previous studies point to inheritable biological properties from vitiligo patients that
might make the melanocyte susceptible to environmental factors or stressors, resulting in
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the death of melanocytes by necrosis or apoptosis. Consequently antigens will be presented,
immune tolerance may be lost, and autoimmunity will be ultimately activated directly
against melanocytes (Boissy and Spritz, 2009; Mahoney and Rosen, 2005).

Indeed, melanocyte-specific autoimmunity is the most accepted and supported
hypothesis to explain melanocyte loss in vitiligo. The coexistence of other autoimmune
diseases with vitiligo (Daneshpazhooh et al., 2006) and the higher frequency of
autoimmune disorders in first degree relatives of vitiligo patients have always been viewed
as strong support for an autoimmune etiology of vitiligo. For example, vitiligo is frequently
associated with autoimmune thyroid disease (Boelaert et al., 2010), alopecia areata
(Ahmed et al., 2007), Addison’s disease (Zelissen et al., 1995), autoimmune polyendocrine
syndromes (Neufeld et al., 1981), and pernicious anemia. In addition, the majority of
vitiligo susceptible genes identified are related to the immune system and autoimmune
diseases (Spritz, 2010).

More direct evidence in favor of autoimmune etiology of vitiligo is the presence of
autoantibodies and circulating T-cells directed against melanocytes and their components.
Moreover, the margins of active generalized vitiligo lesions have been shown to be
infiltrated with cytotoxic T-cells which are thought to play a primary role in melanocyte
loss (Le Poole and Luiten, 2008; Ongenae et al., 2003). Furthermore, the elevated ratio of
CD8+ to CD4+ T-cells found in vitiligo patients further supports a role of cell-mediated
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immunity in vitiligo. Analysis of epidermal cytokines at sites of vitiligo lesions revealed
increased levels of soluble IL-2, IL-6 and IL-8, suggesting a role of inflammatory
immunity in vitiligo pathogenesis (Mandelcom-Monson et al., 2003). Moreover, an
imbalance of cytokines can affect melanocyte activity and survival even though the exact
roles in vitiligo pathogenesis of these inflammatory cytokines remain to be determined.
Along with a role of cell-mediated immunity in vitiligo, humoral immunity was also found
to contribute to the loss of melanocytes in this disorder. Antibodies to melanocytes occur at
a significantly increased frequency in the sera of vitiligo patients compared with healthy
individuals (Cui et al., 1992). The ability of melanocyte-specific autoantibodies to kill
melanocytes was eloquently demonstrated in vivo. By grafting human skins onto nude
mice that were injected with purified IgG obtained from vitiligo patients showed
melanocyte loss in this model system. This in vivo approach demonstrated the ability of
melanocyte-specific autoantibodies to kill melanocytes (Gilhar et al., 1995).
Vitiligo-associated antibodies were also shown in vitro to be able to destroy melanocytes
by antibody-dependent cellular cytotoxicity and complement-mediated lysis
(Gottumukkala et al., 2006). Targets of vitiligo autoantibodies have been reported to
include tyrosinase (TYR) (Song et al., 1994), tyrosinase-related protein 1 (TRP1) (Li et al.,
2010), TRP2 (Okamoto et al., 1998), tyrosine hydroxylase (Kemp et al., 2011), lamin A
(Li et al., 2010), melanosomal matrix protein pg100 (Pmel17) (Kemp et al., 1998), and
melanin-concentrating hormone receptor 1(MCHR1) (Li et al., 2010). In summary,
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autoimmunity is the most comprehensive and widely accepted hypothesis for vitiligo with
reasonable certainty.

Oxidative stress may also play an important pathogenic role in vitiligo. It is believed to
be an initial event causing melanocyte degeneration in vitiligo development. Notably,
studies in vitro have provided a link connecting cellular oxidative stress with autoimmune
diseases (Dell’Anna and Picardo, 2006). Other studies also have indicated that intrinsic
damage to melanocytes could be the initiating event in vitiligo development leading to
recognition of melanocytes proteins and development of melanocyte specific immunity
and progressive immune mediated loss of melanocytes (Van den Boorn et al., 2011; Le
Poole and Luiten, 2008). Oxidative stress originally results from either decreased levels of
antioxidants such as glutathione, catalase and vitamin E or increased levels or reactive
oxygen species, like superoxide anion, hydrogen peroxide and hydroxyl radicals. It is
suggested that the imbalance in the oxidant-antioxidant system, which is probably due to
melanocyte deficiency rather than oxidative stress, might play such roles in vitiligo
(Bagherani et al., 2011). Nevertheless, melanocyte cultures from vitiligo patients exhibited
intracellular hyperproduction of ROS (Dell’Anna and Picardo, 2007). Vitiligo melanocytes
were found to be susceptible to external oxidative stress and UV radiation (Jimbow et al.,
2001).

In summary, despite years of intensive investigations, the exact pathogenesis of
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vitiligo still remain to be defined, and it is anticipated that the discovery of biological
pathways leading to development of the disease will provide novel therapeutic targets for
future treatment and improve the quality of human life.

Treatment

Vitiligo can cause serious emotional stress and treatment of this aspect could be very
important to vitiligo patients. Few studies have paid attention to the effects of treatment
interventions on the psychosocial consequence of vitiligo. Currently, repigmentation rate
occurs in 1 %-25 % of treated cases (James, 2006). The goal of vitiligo treatment is to halt
the progression of depigmentation and try to induce repigmentaion in the white patches.
These treatments mainly include prescription medicine, surgical therapy, and skin
camouflage techniques.

Medical therapies either use topical steroid or psoralen. Topical steroid therapy is one
of the most widely used vitiligo treatments for repigmentation of white patches. Steroids
are potent suppressors of immunity and have proven beneficial in treatment of autoimmune
diseases. Topical steroid therapy is used in the form of topical creams and ointments during
the early stages of vitiligo. Psoralenphoto chemotherapy is also known as psoralen and
ultraviolet A. Psoralen is a natural compound found in the seeds of Psoraleacorylifolia.
After the depigmented area is exposed to ultraliolet A light, psoralen is either taken by
mouth or applied to the depigmented area of skin and this sensitizes the skin to
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repigmentation. Despite the photocarcinogenic properties of psoralen, it was used as a
tanning activator in sunscreens until 1996 (Autier et al., 1997). Moreover, depigmentation
is an alternative way to achieve medical therapy. Depigmentation involves the use of
melanocytotoxic agents or photothermolysis to bleach the remaining pigmented areas or to
match white areas in patients with vitiligo (Garg et al., 2010).

Surgical therapy is the latest vitiligo treatment which consists of autologous skin
grafts, epidermal blister grafting, and autologous melanocytes transplants, but all these
treatments must be considered only after less invasive medical therapies have failed
(Khunger et al., 2009).

Skin camouflaging is the art of disguising blemishes on the skin by using special
creams without treating its underlying cause. Camouflage therapy varies from
camouflage products, self-tanning dyes and tattooing. The dermatology life quality index
of patients with camouflage improved significantly when compared with that of patients
without camouflage (P < 0.005) (Tanioka et al., 2010).

In general, because the pathogenesis of vitiligo is still not clear, there is a plethora of
different treatments. None of these treatments appear to be effective to treat all types of
vitiligo, and hence may either be used alone or in combination depending on clinical type
and stability of vitiligo, age of patient and other factors.
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Biology of melanocytes

Melanocytes are dendritic, melanin-producing cells located in the bottom layer of
the skin epidermis that are responsible for the pigmentation of skin, hair and eyes through
the process of melanogenesis. Each melanocyte in the epidermis has several dendrites
that stretch out to connect it with many keratinocytes located in the basal layer. Through
these connections, melanosomes, vesicles containing the endogenous photoprotectant
melanin, will be transferred from melanocytes to keratinocytes. Together, the cells in the
epidermal layer of the skin form a barrier against environmental damage such as
pathogens (bacteria, fungi, parasites, and viruses), heat, UV radiation and water loss.

Melanocyte development

Except for pigmented epithelium of the eyes, all other pigment cells in vertebrates
are derived from the neural crest that arises from the dorsal part of the neural tube or
neural folds early during embryonic development. Depending on the axial level, the
neural crest can be a source of bone, cartilage and adipose tissue, endocrine cells, neurons
and glial cells and melanocytes. The choice of migratory pathway is determined by both
lineage specification and expression of signaling molecules (Erickson and Goins, 1995).
Committed precursors for melanocytes are termed melanoblasts.
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Several transcriptional factors are crucial to melanoblast lineage commitment and
migration behavior. Microphthalmia-associated transcription factor (MITF) is required
for development of neural crest-derived melanocytes. Loss of MITF will result in the
absence of melanocytes (Mochii et al., 1998). In addition to MITF, stem cell growth
factor (SCF) has a crucial role in permitting melanoblast survival and promoting
proliferation, both during initial and later migration (Mackenzie et al., 1997). Other
factors including endothelin-1 and -3, hepatocyte growth factor and basic fibroblast
growth factor are involved in different stages of melanocyte migration from the dermis
into the epidermis in humans (Scott et al., 1997).

Melanogenesis

The main function of melanogenesis is to protect skin from UV radiation. Upon the
exposure of the skin to UV radiation, melanogenesis is enhanced by the activation of the
key enzyme TYR which is a glycoprotein located in the membrane of the melanosome.
The structure of TYR includes an inner melanosomal domain that contains the catalytic
region (90 % of the protein), a short transmembrane domain and a cytoplasmic domain
composed of 30 amino acids (Kwon et al., 1987). It has been shown that histidine
residue-binding copper ions located in the inner portion of TYR are required for TYR
activity (Hearing and Jimenez, 1987). Two types of melanin are synthesized within
melanosomes: a dark brown-black insoluble polymer eumelanin and a light red-yellow
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sulphur-containing soluble polymer pheomelanin (Prota, 1995). TYR catalyses the first
two steps of melanin synthesis: the hydroxylation of L-tyrosine to
L-dihydroxyphenylalanine (L-DOPA) and subsequent oxidation of this L-DOPA to the
corresponding quinone, L-dopaquinone (Ito et al., 1984).

Following the formation of L-dopaquinone, the melanin pathway is divided into
synthesis of the black-brown eumelanin and red-yellow pheomelanin. In the eumelanin
pathway, there is spontaneous conversion of L-dopaquinone to dopachrome. Dopachrome
is either spontaneously converted to 5,6-dihydroxyindole or is enzymatically converted to
5,6-dihydroxyindole-2-carboxylic acid by TYR-related protein-2 (TRP2) functioning as
dopachrometautomerase (DCT). TYR-related protein-1 (TRP1) converts the oxidation of
5,6-dihydroxyindole-2-carboxylic acid to a carboxylated indole-quinone at a downstream
point in the melanin biosynthetic pathway (Takeshi, 1994). Finally, the polymerization of
indole and quinines leads to eumelanin formation (Prota, 1988). The pheomelanin pathway
branches from the eumelanin pathway at the L-dopaquinone step and is dependent on the
presence of cysteine which is actively transported through the melanosomal membrane.
Cysteine reacts with L-dopaquinone to form cysteinyl-dopa (Prota, 1988). Then
cysteinyl-dopa is converted to quinoleimine, then to alanine-hydroxyl
dihydrobenzothazine and polymerizes to form pheomelanin.
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TRP1 and TRP2, which are structurally related to TYR and share approximately 40 %
amino acid homology, span the melanosomal membrane like TYR. It has been suggested
that TRP1 increases the ratio of eumelanin to pheomelanin (del Marmol et al., 1993).
However, except for the role in melanogenesis, other roles of TRP1 and TRP2 in
melanocyte survival and response to oxidative stress are not yet clarified.

Melanin has an important role in oxidative homoeostasis in skin. Eumelanin has an
ability to scavenge and quench both oxygen- and carbon-derived free radicals
(Rozanowska et al., 1999). Pheomelanin does not have these properties and can even be a
source for free radical production upon UV irradiation (Larsson 1993).

Melanogenic regulation

Melanogenesis is regulated in part by paracrine melanogenic stimulators. These
stimulators include proopiomelanocortin (POMC)-derived peptides: alpha-melanocyte
stimulating hormone (α-MSH), β-MSH and adrenocorticotropic hormone (ACTH) (Thody
and Graham, 1998). Cui et al. (2007) showed that p53 activation upon UV radiation
(UVR) exposure stimulates transcription of the POMC promoter in keratinocytes, thus
increasing the release of POMC-derived α-MSH, a key physiological inducer of
melanogenesis. The biological function of keratinocyte-derived α-MSH is then mediated
through its binding to the melanocortin 1 receptor (MC1R), the only melanocortin
receptor expressed in melanocytes. MC1R is a G protein-coupled receptor that activates
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adenylate cyclase and cAMP production. The increased intracellular concentration of
cAMP mediates the melanogenic response to α-MSH, resulting in increased production of
melanin. In general, α-MSH has a key role in the melanogenic response after exposure to
UVR. Increased cAMP is followed by activation of protein kinase A (PKA) in
melanocytes (Roesler et al., 1998). PKA induces transcription of the MITF gene. In turn,
MITF efficiently activates transcription of genes encoding melanogenic enzymes.

During the past decade, scientists found that MITF not only affects melanocyte
development, but also pigmentation via its regulatory effects on transcription of TYR,
TRP1 and TRP2 (Goding, 2000). MITF also was shown to be a key transcriptional factor
for Rab27A which is an important protein for melanosome transport (Chiaverini et al.,
2008). Moreover, MITF also regulates expression of Pmel17, Melan-A, and ocular
albinism type 1 (OA1) proteins which are involved in the formation of the melanosomal
matrix and in melanosome maturation (Berson et al., 2001). Therefore, MITF plays a
crucial role in melanin synthesis as well as melanosome biogenesis and transport.

The Smyth line (SL) chicken overview – Avian model for human vitiligo

The Smyth line of chickens, previously known as the DAM (delayed amelanotic)
chickens, was developed by Poultry Geneticist Dr. J. Robert Smyth, Jr. at the University of
Massachusetts in Amherst in the 1970s. Vitiligo was first observed in 1971 in a hen from
the Massachusetts Brown line (BL) population maintained at the University of
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Massachusetts’ Poultry Research Center in Amherst, MA (Smyth et al., 1981). This hen
exhibited post-natal, vitiligo-like loss of pigmentation. By back-crossing the vitiliginous
hen with BL males and selecting for vitiligo, the SL line was established. Serotyping of the
SL population identified three major histocompatability complex (MHC) haplotypes: B101,
B102, and B103, and sublines of the SL population homozygous to each MHC haplotype
were developed. Three MHC sublines of SL (SL101, SL102, and SL103; B101/101, B102/10,
and B103/103, respectively), three MHC-matched parental BL (BL101, BL102, and BL103)
control lines and one other control line, the Light Brown Leghorn (LBL101) were initially
maintained. With the retirement of Dr. Smyth in 1996 and the closure of the poultry farm at
the University of Massachusetts, SL101 and MHC-matched control lines BL101and
LBL101were relocated to University of Arkansas. All three lines currently are maintained
by Dr. Gisela F. Erf at the Poultry Farm at the University of Arkansas, Division of
Agriculture in Fayetteville, Arkansas. Over the years, this chicken model has made
significant contribution to the understanding of the components and mechanisms involved
in vitiligo and autoimmune diseases in general. SL101, BL101, and LBL101 lines of
chicken are the only remaining genetic lines of chicken animal model for vitiligo.

Characteristics of Smyth line and control chickens

The SL of chickens is a valuable and excellent animal model for human vitiligo. SL
27

chicks have normal pigmentation at hatch with brown feathers and dark eyes. In general,
SL vitiligo (SLV) chickens exhibit a postnatal, spontaneous, vitiligo-like, melanocyte loss
in the feather (Erf, 2010), displaying all the characteristics of the human disorder (Wick et
al., 2006). Under conventional rearing conditions, onset of pigmentation loss in the
feathers typically occurs when the chickens are between 6 and 20 weeks of age (young
adult) and the incidence of SLV in the SL population ranges between 80% and 95%. The
severity varies from a few affected feathers to complete feather depigmentation (Erf, 2010).
In addition, SL chickens also exhibit other autoimmune diseases like uveitis, autoimmune
thyroiditis and an alopecia-like feathering defect (Smyth et al., 1981; Smyth and McNeil,
1999). Interestingly, SL chickens that carry the Id sex-lined recessive dermal pigmentation
gene (SL-G), resulting in grey-pigmented shanks in id females and id/id males, very rarely
develop SLV (< 5% incidence, Pillai, 1998).

The SL chickens together with the BL parental control (< 1% vitiligo) and the LBL
vitiligo resistant control have been established as a very important model for spontaneous
vitiligo (Erf, 2010).

Pathogenesis

The exact etiopathology for SLV, like human vitiligo, is not clearly understood,
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Similar to human vitiligo, SLV is a multifactorial disorder whereby the expression of SLV
involves the interaction between genetic susceptibility, immune system components and
environmental factors that trigger the expression of the disorder.

SL chickens exhibit a genetic predisposition to the development of SLV which appears
to be manifested in part by an inherent melanocyte defect. As reported by Boissy et al.
(1984) established SL embryo-derived melanocyte cultures were initially indistinguishable
from BL embryo-derived melanocytes. With increased age and passage of cultures, the SL
melanocytes became irregularly shaped and developed fewer dendrites than BL control
melanocytes. Similar abnormities were also observed in the feather tissue of SL chickens
(Boissy et al., 1984). Melanocytes in growing feathers exhibit morphological
abnormalities including shrinkage of melanocyte-cell bodies and dendrites and abnormally
shaped melanosomes with pigmented membrane extension several weeks before SLV
development (Boissy et al., 1983).

However, the inherent melanocyte defect alone is insufficient to lead to SLV without
an active immune system (Smyth, 1989). The inherent melanocyte defect does however
appear to play a role in provoking a melanocyte-specific autoimmune response. Both
cell-mediated and humoral melanocyte-specific immune activities have been demonstrated
in chickens with SLV. Cell-mediated immune mechanisms appear to be responsible for the
melanocyte loss and to play a key role in the pathogenesis of SLV (Erf et al., 1995, Wang
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and Erf, 2004). Immunophenotypic analysis of the feather infiltrating leukocytes revealed
the infiltration of more CD8+ cells than CD4+ cells in this target tissue (Erf et al., 1995;
Shresta et al., 1997; Shi and Erf, 2012) whereby CD8+ T cells rather than CD4+ T cells
were located in close proximity association with apoptotic melanocytes in SL feathers
(Wang and Erf, 2004). Recently, it was shown that the elevated leukocyte infiltration in
early and active SLV was accompanied by increased levels of cytokine expression,
especially in IFN-γ, IL-10 and IL-21, suggesting a Th-1 polarized autoimmune disease
(Shi and Erf, 2012).

The presence of melanocyte-specific autoantibodies in serum from SL chickens with
SLV is also well established (Austin et al., 1992, Shi and Erf, 2012). Previous studies have
shown that TYR is a principal autoantigen in human autoimmune vitiligo (Song et al.,
1994). Additionally, vitiliginous SL chickens were found to have melanocyte-specific
autoantibodies with demonstrated specificity to tyrosinase related protein (TRP) 1(Austin
and Boissy, 1995; Searle et al., 1993) and heat-shock proteins (HSP) 90 (Erf, 2008).
Moreover, these antibodies also bind to chicken as well as human melanocytes (Austin
and Boissy, 1995). A role of B cells in SLV is also suggested by levels of elevated B cell
infiltration in the pulp of growing feathers from SL chicken with active SLV as compared
to SL chickens that never developed vitiligo (Shi and Erf, 2012).

Herpesvirus of turkey (HVT)
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Expression of melanocyte-specific autoimmunity in SLV is greatly augmented in the
presence of environmental factors, such as live herpesvirus of turkey (HVT), a routine live
virus administration at hatch to protect poultry from lymphoma causing Marek’s disease
virus (Erf and Wang, 2001).

To date, HVT has been well established as a reliable trigger of the expression of SLV in
susceptible SL chickens. HVT is an alpha-herpesvirus commonly used in commercial
chicken production as a vaccine to protect chickens from Marek’s disease (T cell
lymphoma) caused by serotype 1 (oncogenic) Marek’s disease viruses (MDV-1). HVT is a
non-oncogenic serotype 3 MDV isolated from turkeys. Like all MDV serotypes it exhibits
strong tropism for feather follicles, where it infects the feather follicle epithelium (Holland
et al., 1998). There were only 10% of non-vaccinated SL chicks raised at biosecurity level
2 that developed vitiligo by 20 weeks of age. This is a dramatic contrast to the greater than
90% incidence of vitiligo observed in SL chickens derived from the same breeder flock and
reared in a conventional poultry house. Careful studies revealed that live HVT
administration appeared to be an important factor in the expression of SLV (Erf et al., 2001;
Erf and Wang, 2001). Moreover, killed HVT had no effect on the expression of SLV,
suggesting that an active infection by HVT is needed to trigger SLV development. Other
live virus vaccines administered at hatch, such as Newcastle disease virus (NDV) or
infectious bronchitis virus (IBV) did not trigger SLV, suggesting that viral infection and
associated anti-viral immune activity, as such, are not responsible for triggering the
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expression of SLV (Erf, 2008). Unlike HVT, NDV and IBV do not translocate to the feather;
hence, the presence of HVT in the feather where melanocytes are located may be a key to
its effect on SLV expression (Holland et al., 1998). In addition, recent studies Marek’s
disease virus (MDV) serotype 1 (MDV1), MDV2, and MDV3 (HVT) revealed that all
three serotypes of MDV are similarly effective in triggering SLV expression in susceptible
SL chickens (Erf, personal communication). Lastly, Bateman (2009) showed that there is
no difference in viral load in the feathers from HVT-vaccinated SL, BL, and LBL chickens
during the 6 weeks sampling period following HVT vaccination.

Oxidative stress overview

Free radicals, such as superoxide anions, hydrogen peroxide, etc, are generated during
normal metabolic activities. The production of these free radicals sometimes provides
advantageous biological effects. The purpose of free radicals during the inflammatory
process is to kill or destroy invading microorganisms (e.g., respiratory burst in activated
phagocytes) and/or to degrade damaged tissue structures (Fantone and Ward, 1982). Free
radicals have been shown to play a role in numerous physiological functions, such as
activation of guanylate cyclase (Mittal and Murad, 1977), control of smooth muscle
relaxation (Ignarro and Kadowitz, 1985), and activation of transcription factor NF- κB, etc.
Uncontrolled release of radicals is involved in the pathogenesis of a number of human skin
disorders, including vitiligo. Under normal circumstances, the body is able to neutralize
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excessive free radicals and prevent them from causing damage. The actual concentration of
free radicals is determined by the balance between their rate of production and rate of
degradation by antioxidants (Evans and Halliwell, 2001). Antioxidants as a balanced
system are used to protect tissues from damage by free radicals that either were produced
physiologically or as a response to inflammation, infection, or disease. An imbalance in the
radical production-degradation system would result in an increased potential for oxidative
stress and bio-molecular damage that is the direct result of free radicals (Halliwell and
Whiteman, 2004).

Recent studies also suggest a role of the antioxidant systems and oxidative stress in the
pathophysiology of vitiligo (Manga et al., 2006). While the exact role of oxidative stress in
vitiligo is unclear, oxidative stress within SL melanocytes has been proposed to be an
extensive threat based upon their local environment. The feather barb ridge, where feather
melanocytes are located, is poorly vascularized and the limited circulation contributes to
the build-up of the free radicals in the barb ridges (Bowers et al., 1999). In humans a
heightened sensitivity of vitiligo-melanocytes to oxidative stress was described and found
to be due to an imbalance and/or a deficiency in their antioxidant system (Manga, 2006).
Similarly, comparisons of SL, BL and LBL embryo-derived melanocyte cultures revealed
heightened production of reactive oxygen species (ROS) and lipid peroxidation in SL
melanocytes compared to control melanocytes (Erf et al., 2005).
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There are both non-enzymatic and enzymatic reactions of antioxidants which can
deactivate free radicals. Non-enzymatic antioxidants include retinoic acid (vitamin A),
α-tocopherol (vitamin E), ascorbate (vitamin C), uric acid, and glutathione (GSH).
Glutathione, also called L-γ-glutamyl-L-cysteinylglycine, is a ubiquitious intracellular
tri-peptide that plays an active role in various cellular functions, including breakdown of
ROS (Deneke and Fanburg, 1989). Glutathione is found in two forms, reduced
glutathione and oxidized glutathione (GSSG). Reduced GSH neutralizes various ROS,
including oxygen free radicals (O 2 ._), hydrogen peroxide (H 2 O 2 ), and hydroxyl radicals
(OH._). These two forms (GSH and GSSG) are recycled between one another through two
enzymes: GSH peroxidase and GSH reductase. GSH peroxidase reacts to form GSSG by
donating hydrogen to the sulfur groups of two GSH molecules. GSSH can also be
converted back to its reduced form via GSH reductase, which reacts with two
β–nicotinamide adenine dinucleotide phosphate (NADPH) molecules. In summary, the
reduction of GSSG to GSH is critical for cellular function. Increased levels of GSSH can
both oxidize cellular proteins and lower the antioxidant capacity (Bottje and Wideman,
1995). Enzymatic antioxidants include catalase, superoxide dismutase and the previously
mentioned GSH reductase and peroxidase. Catalase is a homotetramer with ferriheme at its
active site, which can reduce hydrogen peroxide by oxidation to produce oxygen and water
molecules.

4-tertiary butyl phenol (4TBP) triggers oxidative stress and is toxic to melanocytes
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In humans, phenolic derivatives, such as 4-TBP, have been shown to trigger vitiligo in
susceptible individuals. Exposure to phenolic compounds, specifically 4-TBP, is
widespread in both industrial workers and consumers through contact with synthetic
leather, plastic, glues, and a wide variety of germicidal phenolic detergents. Yang et al.
(1999) reported that occupational vitiligo developed in workers at a 4-TBP
manufacturing factory. The occurrence of vitiligo induced by 4-TBP has been shown to
be related to the duration and intensity of exposure.

Previous studies have shown that 4-TBP is involved in predisposing melanocytes to
the loss of melanin pigment. First of all, 4-TBP is structurally similar to tyrosine, the
initial substrate of TYR in melanin synthesis which was shown to be oxidized by TYR.
The oxidation of 4-TBP yields a toxic intermediate quinone, which further reacts with
cysteine or GSH to produce 4-tert-butyl-6-S-cysteinylcatechol (cys-TBC) and
4-tert-butyl-6-S-glutathionylcatechol (GS-TBC), respectively. Reduced GSH, an
antioxidant, helps protect cells from reactive oxygen species (ROS) such as free radicals
and peroxides. Thus, the loss of reduced GSH results in a weakened ability to overcome
oxidative stress. In general, 4-TBP, a competitive inhibitor of TYR, is metabolized in
melanocytes and is able to cause ROS damage to these cells. Moreover, intermediate
semiquinones which are generated during 4-TBP’s oxidation by TYR facilitate respiratory
electron-transport reactions. Approximately 90% of ROS production can be traced back
to respiratory chain from normal cell metabolism in the mitochondria. The respiratory
35

chain is a major site of premature electron leakage to oxygen, thus being a major site of
superoxide production and driver of oxidative stress. In summary, 4-TBP induced ROS
accumulation may rely on either increase of ROS production during futile respiratory
reaction or decrease the ability of anti-oxidative enzymes such as depletion of GSH.

Phenolic compounds are believed to trigger vitiligo by killing the melanocytes in the
skin through oxidative stress and causing an overload of hydrogen peroxide in the skin.
The expression of most members of the HSP70 family is strongly induced by 4-TBP.
HSP70 in turn induces membrane tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL) expression in human melanocytes to activate dendritic cell activity towards
melanocytes (Kroll et al., 2005). Moreover, Boissy and Manga (2004) showed that human
melanocytes were susceptible to apoptosis following exposure to 4-TBP. These
observations suggest that apoptosis may be another mechanism by which 4-TBP exerts its
toxic effects on melanocytes.

The structure of 4-TBP is similar to tyrosine, the initial substrate of TYR in melanin
synthesis, ironically, expression levels of TYR do not correlate with sensitivity to
4-TBP-induced apoptosis, suggesting an alternative enzymatic mediator may be more
critical. MITF stimulates melanin synthesis by up-regulating expression of melanogenic
enzymes such as TRP1. Elevated expression of TRP1, a key enzyme in melanin
production, significantly increased sensitivity to 4-TBP. Melanocytes that express
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functional TRP1 were significantly more sensitive to 4-TBP than TRP1-null cells. Thus,
normal melanocytes respond to 4-TBP by reducing expression of MITF and TRP1.
However, the role for TRP1 and MITF in the effects induced by 4-TBP in melanocytes
from SL, BL and LBL chickens is unknown.

In summary, 4-TBP competitively inhibits TYR function and triggers accumulation of
ROS in melanocytes by inhibition of GSH activity. However, it is unclear whether ROS
accumulation during 4-TBP exposure is due to increased production from the respiratory
chain and/or inhibition of anti-oxidative enzymes. Additionally, gene expression profiles
related to melanogenesis and apoptosis with respect to 4-TBP treatment are still unknown.

MITF overview

Various environmental and genetic factors affect the development and progression of
vitiligo. Vitiligo development is initially triggered by environmental factors, and then
genetic/epigenetic alterations occur in the skin. This first trigger alters the conditions of
numerous genes and proteins, and the altered gene expression, and protein stability result
in vitiligo progression. MITF is discussed as the master gene for melanocytic survival and
a key transcription factor regulating the expression of TYR, TRP1 and TRP2.

Introduction

MITF is a basic helix-loop leucine zipper protein which plays a predominant role in both
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melanocyte development and regulation of melanogenesis (Hughes et al., 1993). It is not
only expressed in melanocytes, but also in retinal pigmented epithelium, mast-cells,
osteoclasts, and melanoma (Kumasaka et al., 2005; Steingrimsson et al., 2004). MITF
protein forms dimers and binds to specific consensus DNA sequences, such as M-box
promoter elements, in promoter regions of various target genes to regulate proliferation,
melanogenesis and tumorigenesis (Goding, 2000).

Regulation of MITF expression and activity

Several transcription factors directly control MITF gene transcription to regulate
melanocyte development. The first and most important transcriptional factor in
melanogensis is cAMP response element binding protein (CREB). Activation of MC1R
by binding of α-MSH induces cAMP production via activation of adenylate cyclase and
phosphorylates cAMP. Second messager cAMP can activate the protein kinase A, which in
turn response to CREB. Phosphorylated CREB directly binds to the MITF promoter
region and stimulates MITF transcription (Bertolotto et al., 1998). Sry-related HMG box
10 (SOX10) is a high-mobility group (HMG) transcription factor whose presence slightly
correlated with melanocyte development and melanogenesis (Khong and Rosenberg,
2002). SOX10 can positively regulate MITF expression by directly binding to MITF
promoter regions in mice and humans (Bondurand et al., 2000). There are other
transcriptional factors such as paired box 3 (PAX3), signal transducer and activator of
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transcription 3 (STAT3), lymphoid-enhancing factor-1 (LEF-1), immunoglobulin
transcription factor-2 (ITF2) and forkhead-box transcription factor D3 (FOXD3), which
have been reported to induce and/or reduce MITF gene expression to control melanocyte
proliferation (Ping et al., 2011). Furthermore, several factors can modify the MITF
protein after translation. P38 stress-activated kinase induces the phosphorylation at Ser
301 of MITF, and glycogen synthase kinase 3β (GSK-3β) induces Ser 298
phosphorylation, resulting in stimulation of MITF transcriptional activity (Takeda et al.,
2000; Mansky et al., 2002).

Target of MITF

MITF is well known as a master regulator of melanin synthesis. Melanin pigment is
synthesized from tyrosine via an enzymatic and non-enzymatic process. The enzymatic
process is catalyzed by TYR, TRP1 and TRP2, all of which are all regulated by MITF.

Another important gene regulated by MITF is an anti-apoptotic gene B-cell
leukemia/lymphoma 2 (BCL2) which is widely expressed in human melanomas (Selzer et
al., 1998). Oxidative stress from environmental factors, such as UV radiation, causes DNA
damage and apoptosis. BCL2 has been identified as an MITF target gene and has been
shown to be partially important for cell rescue from oxidative stress-induced apoptosis in
MITF-depleted cells (Yajima et al., 2011).
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In addition to the MITF requirement for development of neural crest-derived
melanocytes, MITF also has been shown to be involved in cellular events for the initiation
of tumorigenesis. MITF directly binds to the promoter regions of P16Ink4a, P21Cip1, and
Cyclin D1 and induces their transcription (Carreira et al., 2005; Loercher et al., 2005).
These genes are well-known to be related to melanoma formation.
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Abstract

The Smyth line (SL) chicken model for vitiligo exhibits spontaneous, autoimmune loss of
MCs in growing feathers. It is an excellent animal model for human autoimmune vitiligo.
Skin exposure to phenolic derivatives, such as 4-tertiary butyl phenol (4-TBP) can trigger
vitiligo in susceptible individuals by inducing oxidative stress that is more readily
overcome by melanocytes (MCs) from normally pigmented individuals than from
individuals with vitiligo (Manga et al., 2006). MC degeneration and/or destruction in
vitiligo may be enhanced or initiated by oxidative stress. The mechanism of 4-TBP on MC
loss in vitiligo is currently unclear. In this study, the generation of reactive oxygen species
(ROS) in response to 4-TBP exposure of MC-containing feather tissue (MC-FT, newest 3
mm growth of growing feathers) and MCs derived from growing feathers (MC-F) or from
the neural crest of 72 h embryos (MC-E) was examined. MC-FT were collected from SL
chickens (80 - 95% vitiligo incidence), SL chickens with dermal (grey) pigmentation of the
shanks (SL-G, < 5% vitiligo), Brown line chickens (BL, parental control, < 1% vitiligo)
and Light Brown Leghorn (LBL, vitiligo resistant control) chickens at 1, 4, 7, and 12 weeks
of age (prior to and after SL vitiligo (SLV) development). To examine the influence of
turkey herpesvirus HVT administration at hatch on the response of MC to 4-TBP, the ROS
generation in MC-FT was measured from chickens with and without HVT vaccination.
Independent of HVT treatment and age, 4-TBP induced more oxidative stress (P < 0.05) in
MC-FT of SL at 1 h co-culture with 4-TBP than SL-G, BL, and LBL chickens. Similar
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results were also observed in SL, SL-G, and BL MC-F and MC-E cultures exposed to
4-TBP. As expected, ROS production was not observed in white SLV MC-FT (no MCs)
stimulated with 4-TBP. Elevated ROS production in response to 4-TBP in SL MC-F and
MC-E was accompanied by increased RNA expression levels of tyrosinase related
protein-1 (TRP1) post 1 h culture with 4-TBP, whereas normal MCs from SL-G and BL
chicken responded to 4-TBP by reducing expression of microphthalmia-associated
transcription factor (MITF) and TRP1 to protect MC from further oxidative stress. By
comparison with gene expression in MC-FT, only the relative MITF expression was
reduced in SL-G, BL, and LBL chickens. Taken together, these data suggested a
heightened sensitivity of MCs to 4-TBP in vitiligo-prone SL chickens. The reduced ability
to withstand oxidative stress in SL chickens may due to a disruption in MITF regulation.
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Introduction

Vitiligo is an acquired pigmentary disorder characterized by a loss of epidermal
melanocytes (MCs) and depigmentation of the skin (Lerner and Nordlund, 1978). This
disease is found in 0.1 - 2 % of the world’s human population (Lerner, 1971). MC death
results in the loss of pigment protection of the skin from solar damage. Although the
etiopathological mechanisms of this disease are not well understood, it is known that many
factors contribute to vitiligo susceptibility, including genetic factors, environmental
components and immune system involvements (Reza, 2011). Exposure to specific
chemotoxins, which include phenol derivatives such as 4-tertiary butyl phenol (4-TBP),
appears to be an environmental trigger for human vitiligo (Boissy and Manga, 2004),
altering MC gene expression and protein stability and activity, and resulting in vitiligo
expression and progression in susceptible individuals (James et al., 2006).

Manga et al. (2006) demonstrated that 4-TBP induced oxidative stress in cultured MCs
could be more readily overcome by MCs from normally pigmented individuals than from
individuals with vitiligo. 4-TBP is structurally similar to tyrosine, the initial substrate of
tyrosinase (TYR) in melanin synthesis, and like tyrosine, has been shown to be oxidized by
tyrosinase. The oxidation of 4-TBP yields toxic intermediate semiquinones which facilitate
respiratory electron-transport reaction, a major site of premature electron leakage to
oxygen (Kirsten et al., 2000). Thus, the oxidation of 4-TBP in MCs results in the
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generation of reactive oxygen species (ROS). In addition, intermediate quinine can further
react with cysteine or glutathione (GSH) to produce 4-tert-butyl-6-S-cysteinylcatechol and
4-tert-butyl-6-S-glutathionylcatechol, respectively (Kirsten et al., 2000). The loss of GSH,
an antioxidant protecting cells from ROS, results in the inability of MCs to overcome the
oxidative stress induced by exposure to 4-TBP. While the exact role of oxidative stress in
vitiligo is unclear, it has been shown to play a role in the development of the disorder
and/or the progressive loss of MCs.

Previously, it has been shown that MCs cultured in the presence of 4-TBP experience
dose-dependent apoptosis and the percentage of cells that die following exposure to
4-TBP can be significantly reduced by excluding α-melanocyte-stimulating hormone
(α-MSH; Yang et al., 1999). α-MSH is a key physiologic inducer of melanogenesis. The
biological function of α-MSH is mediated through its binding to MC1R, the only
melanocortin receptor expressed in MCs (Pavey and Gabrielli, 2002). MC1R is a G
protein-coupled receptor that activates adenylate cyclase. Therefore, the increased
intracellular concentration of cAMP mediates the expression of the MC-specific isoform of
the microphthalmia-associated transcription factor (MITF; Widlund and Fisher, 2003).
MITF in turn activates the expression of many downstream genes, including TYR,
tyrosinase-related protein (TRP) 1 and TRP2, resulting in melanogenesis.

Although MITF is an important factor in MC development, survival, and differentiation,
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recent studies have shown that MITF is the substrate of caspases and plays a key role in the
apoptosis of melanoma cells (Larribere et al., 2005). B-cell lymphoma 2 (BCL2), an
anti-apoptotic factor, has been shown to directly interact with MITF and MITF regulates
endogenous levels of BCL2 in MCs (Larribere et al., 2005). BCL2 expression is very
critical for MC survival. Further studies also showed that levels of heat shock protein (HSP)
70 were elevated in MCs in response to 4-TBP exposure. Elevated HSP70 subsequently
activated dendritic cell (DC) effector functions towards stressed MCs (Kroll et al., 2005).
Since MCs are preferentially targeted in vitiligo, we considered MITF and its downstream
regulated genes TYR, TRP1 and TRP2, apoptosis related genes BCL2 and BCL2
homologous antagonist/killer (BAK1), and HSP70 as ideal candidates to examine MC
stress induced by 4-TBP in the vitiligo prone Smyth line (SL) chickens.

The SL of chickens is a well-established animal model for the study of spontaneous
development of autoimmune vitiligo, displaying all the characteristics of the human
disorder (Smyth, 1981 and 1989; Wick et al., 2006; Erf, 2010). Like human vitiligo, SL
vitiligo (SLV) is a multifactorial disorder involving genetic susceptibility, environmental
triggers, and cellular as well as humoral immune system components in the progressive
loss of MCs. Under conventional rearing conditions including routine administration of
turkey herpesvirus (HVT) at hatch, approximately 80 - 95 % of SL chickens develop SLV
between 6 - 20 weeks of age. Without the HVT environmental trigger, the incidence of SLV
is reduced to < 20% (Erf and Wang, 2001). Additionally, SL chickens that carry the Id
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sex-lined recessive dermal pigmentation gene, resulting in grey-pigmented shanks (SL-G),
very rarely develop SLV (< 5% incidence, Pillai, 1998). SL and SL-G chickens together
with MHC-matched the Brown line (BL) parental control (< 1% vitiligo) and the Light
Brown Leghorn (LBL; vitiligo-resistant) control chickens constitute an excellent animal
model to study vitiligo. Another excellent attribute of the SL chicken model for vitiligo is
the location of MCs in the growing feathers, rather than the skin (Figure 1). Growing
feathers are easily and repeatedly accessible for sampling, providing unique opportunity to
examine the evolving lesion prior to and throughout the development of SLV in the same
individuals. Additionally, MC cultures can be established from growing feathers as well as
from the neural crest of 72 h embryos for in vitro study of MCs that differentiated in
different environments.

In this study, we explore the hypothesis that MCs from vitiligo-prone SL chickens are more
sensitive to 4-TBP treatment than MCs from SL-G, BL and LBL chickens. To address this
hypothesis, the objectives of the current study were to examine the production of ROS and
monitor gene-expression of HSP70 and melanogenesis- and apoptosis-related proteins in
response to 4-TBP exposure of MC-containing feather tissue (MC-FT, newest 3 mm
growth of growing feathers) and MCs derived from growing feathers (MC-F) or from the
neural crest of 72 h embryos (MC-E). Characterization of these pathways will shed more
light on the underlying etiology of MC loss in response to 4-TBP.
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Materials and Methods

Animals

Three lines of MHC-matched (B101/101) chickens were used for this study: 1) the
vitiligo-prone SL chickens which exhibits an 80 - 95 % incidence of SLV by 20 weeks of
age under conventional rearing conditions and SL chickens with grey shanks (SL-G). Since
the establishment of SL breeder populations at the University of Arkansas, none of the
B101/101 SL-G chickens (id+ females and id+/id+ males) have been observed to develop SLV
by 20 weeks of age (natural end-point of SLV development in adult chickens), 2) the
parental BL control chickens (< 1% incidence of vitiligo), and 3) the vitiligo-resistant LBL
control line of chickens (no incidence of vitiligo; Erf, 2010). On the day of hatch, chicks
from each pedigreed family were tagged using a color coded numbering system and were
randomly assigned to two groups. Chicks in Group 1were vaccinated for Marek’s disease
by s.c. injection with cell-free lyophilized live HVT vaccine (0.2 mL, est. 8000 pfu)
following the manufacturer’s instructions (MD-Vac CFL serotype 3, live, Fort Dodge
Animal Health, Fort Dodge, Iowa) and reared in floor pens on wood-shavings litter on the
conventional Arkansas Experiment Station, University of Arkansas Poultry Farm in
Fayetteville, Arkansas. Siblings of Group 1 chicks were not vaccinated with HVT (Group 2)
and reared in floor pens on wood-shavings litter in a HEPA-filtered room at the Arkansas
University of Arkansas, Division of Agriculture, Poultry Health Laboratory. Under these

61

conditions, the incidence of SLV in HVT-negative chickens has been repeatedly shown to
be less than 10% (Erf, personal communication). All chicks were shown the location of
food and water and the well-being of the chicks were checked daily. Food and water were
available ad libitum and standard temperature and lighting protocols were followed. All
procedures for this study were approved by the Institutional Animal Care and Use
Committee (IACUC) Protocol #08011.

Establishment of MC-F cultures from feathers in vitro

MC-F cultures were prepared from each 12-week-old 10 SL, 6 SL-G and 6 BL growing
feathers following a modified procedure (Boissy et al., 1987). Briefly, MCs isolated from
feathers were incubated at 40.5oC in a humidified incubator with 5 % CO 2 in complete
Ham’s F12 medium supplemented with 10 % BSA, 1% glutamine-penicillin-streptomycin,
1% fungizone and 85 nM TPA. The culture medium was changed every 3 to 4 days. When
the cells reached 50 - 70% confluence they were subcultured. Cultures at passage 4 to 5
were used for this study. Twenty-four hours before treatment, all MC-F cultures were
cultured in MC-F culture medium without TPA and phenol red (RPMI 1640 medium
without phenol red containing 10% FBS, 1% L-glutamine/penicillin/streptomycin, 1%
fungizone, and 5% μg/mL insulin). These cultured MC-F were used for ROS generation
and gene expression analysis to examine the effect of 4-TBP treatment. Specifically, 100
µL of 0 µM, 400 µM and 2000 µM 4-TBP was added to each well containing 1 x 104
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MC/well (triplicate cultures; final 4-TBP concentration of 0 µM, 200 µM and/or 1000 µM)
in a 96-well flat-bottom tissue culture microtiter plate. Cultures were then incubated for 1 h
at 40.5°C humidified incubator with 5% CO 2 before subjected to ROS analysis. For gene
expression analysis, 1 x 106 MC/well were cultured in triplicates for 1 h with 0 µM or 200
µM 4-TBP in a 24-well flat-bottom tissue culture plate as described above.

Establishment of MC-E cultures from embryos in vitro

A modified method based on Boissy and Halaban (1985) was used to establish MC-E
cultures from the neural crest of embryos. Briefly, fertilized 10 SL, 6 SL-G and 6 BL eggs
from different hens were incubated at 40.5 °C for 72 h. Following careful removal of the
embryo, the posterior portion of the embryonic trunk containing the neural crest was
dissected and trimmed to obtain the neural crest. The neural crest was incubated at 40.5°C
in a humidified incubator with 5% CO 2 in embryo-MC culture medium [10% FBS, 5%
NuSerum (Becton Dickson Labware, Bedford, MA, USA), 1%
L-glutamine/penicillin/streptomycin, 1% fungizone, 80 nM
12-O-tetradecanoylphorbol-l3-acetate (TPA) and 40 ng/mL cholera toxin in Ham’s F10
medium]. After 72 h of incubation, the neural crest was removed and discarded, and the
attached MCs remained in the culture plate. The culture medium was changed every 3 to 4
days. When the cells reached 50 - 70% confluence they were subcultured. Cultures at
passage 4 to 5 were used for this study. Twenty-four hours before treatment, MC-E cultures
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were cultured in MC-E culture medium without TPA, cholera toxin, and phenol red (10%
FBS, 5% NuSerum (Becton Dickson Labware, Bedford, MA, USA), 1%
L-glutamine/penicillin/streptomycin, 1% fungizone in 1640 medium). These cultured
MC-E were used in ROS generation assays and for gene expression analysis to examine the
effect of 4-TBP treatment as described for MC-F above.

Establishment of MC-FT cultured with 4-TBP in vitro

Ten SL, 6 SL-G, 10 BL, and 10 LBL HVT-vaccinated chickens (Group 1) and the same
number of siblings from Group 1 (not HVT-vaccinated; Group 2) were used in this study.
For each chick, 7 growing feathers were collected from each wing at 1 week of age and
from each breast track when the chickens were 4-, 7- and 12-weeks of age. The feather tips
(Figure 1) from each bird were stored separately in PRMI 1640 medium without phenol red
on ice until use. For tissue culture, the bottom 3 mm newest melanocyte-containing growth
(MC-FT) (Figure 1) of each feather tip was cut, weighed and cultured in complete-culture
medium [RPMI 1640 without phenol red containing 10% FBS, 1%
L-glutamine/penicillin/streptomycin, 1% fungizone, and 5% μg/mL insulin] for 1 h at
40.5°C in a humidified incubator with 5% CO 2 . These cultured MC-FT were used for ROS
generation and gene expression analysis to examine the effect of 4-TBP treatment.
Specifically, 7 MC-FT from each bird were used for ROS examination. For this, 1 MC-FT
per well was randomly assigned to wells in 96-well flat-bottom tissue culture microtiter
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plates as follows: 3 MC-FT were cultured in medium without 4-TBP stimulation
(unstimulated control group), 3 MC-FT were cultured in medium with 200 µM 4-TBP
(treatment group), and 1 MC-FT was cultured in medium to determine background
fluorescence in the ROS assay. For use in gene-expression analysis 6 MC-FT were cultured
as described above (3 MC-FT without 4-TBP stimulation and 3 MC-FT with 200 µM
4-TBP treatment).

Assay for ROS generation

The MC-FT, MC-F, and MC-E cultures were incubated with 2',7'-dichlorofluorescindiacetate (DCF-DA; D-6883, Sigma, St. Louis, MO, USA), and ROS generation was
measured using a kinetic read method (every 10 minutes for 90 minutes) on a micro-plate
reader with an excitation wavelength of 485 nm and an emission wavelength of 530 nm.
The slope of ROS generation for each sample was calculated and expressed as fluorescence
units/min (f.u./min). For MC-F and MC-E cultures, the slope (f.u./min) of ROS generation
was determined for each 4-TBP treatment (0, 200, and 1000 µM in MC-F cultures; 0 and
200 µM in MC-E cultures). For the analysis of ROS generation in the MC-FT, the slope of
ROS generation over time (f.u./min) from untreated samples was subtracted from the slope
(f.u./min) of 4-TBP-treated samples before data analysis of 4-TBP induced ROS
generation.

RNA extraction, quantification, and cDNA synthesis
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Total RNA was isolated from collected MC-E, MC-F, and MC-FT cultures using the
RNeasy® Mini Kit (Qiagen, Valencia, CA) and following the protocol for “Purification of
Total RNA from Animal Tissues” with modifications. MC-FT were homogenized by
Tissue Tearor (BioSpec Products, Bartlesville, OK, Model: 985370-395) provided in the
kit, whereas, MC culture were homogenized in lysis buffer by vortex. Total RNA was
isolated from homogenates with on-column DNA digestion (Qiagen). RNA was eluted in
30 µL RNase-, DNase-free water and stored at -80°C until use. RNA quality and quantity
were determined by ExperionTM RNA StandardSens Reagents and Supplies (Bio-Rad
Laboratories, Hercules, CA) following the manufacturer’s instructions. RNA (175 ng) was
reverse transcribed into cDNA by High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Foster City, CA) in a 10 μL reaction volume according to the
manufacturer’s instruction. A Biometra® personal cycler (Biomedizinische Analytik
GmbH, Germany) was programmed as follows: 25ºC for 10 min, 37ºC for 2 h, 85ºC for 5
min and 4ºC holding temperature. Then cDNA was stored at -80ºC until further analysis.

Taqman® quantitative PCR (qPCR)

Primer and probes are shown in Table 1. qPCR was performed in 25 μL reaction volume on
an ABI PRISM 7300 sequence detection system (Applied Biosystems, Foster City, CA)
using the Universal PCR Master Mix (Applied Biosystems, Foster City, CA) and following
the manufacturer’s instruction. In each plate, a calibrator sample (a pool of cDNA from
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age-matched BL birds from control group), a non-template control, and sample cDNA
were included. For each sample 28S ribosomal RNA served as the endogenous control
gene. Cycling profiles used were: 94ºC for 15 min, and 50 cycles of denaturation at 94ºC
for 60 s, and annealing/extension at 60ºC for 60 s. The relative gene expression was
determined by the delta delta Ct (∆∆Ct) method (Wong and Medrano, 2005).

Statistical Analysis Statistical Analysis

For in vitro MC-FT, two-way analysis of variance (ANOVA; JMP Pro 9, JMP Software Inc.,
Cary, NC) using the full factorial model procedure and Fisher’s LSD multiple means
comparisons was carried out to investigate the main effect of type of chicken (SL, SL-G,
BL, and LBL), the main effect of HVT (HVT and non-HVT group) and their interaction on
the generation ROS and expression of the various target genes examined. In the absence of
line of chickens by HVT interaction (P > 0.1), the data were pooled across HVT and the
main effect of type of chicken was presented. Two-way and/or one-way ANOVA was also
used to analyze MC-F and MC-E ROS generation and gene expression for each line with or
without 4-TBP treatment. In the presence of significant main effect(s), as determined by
ANOVA, Fisher’s LSD multiple means comparison was used to determine differences
among groups means. P values ≤ 0.05 were considered significant. Data were reported as
means ± SEM.

Results
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ROS generation in SL, SL-G, BL and LBL MC-containing feather tissue (MC-FT)
cultures in response to 4-TBP treatment

To examine the effect of 4-TBP treatment on ROS generation, the slope of fluorescence
(f.u./min) from untreated samples was subtracted from the 4-TBP treated samples.
Two-way ANOVA revealed that ROS generation (f.u./min) in response to 4-TPB was not
affected by HVT vaccination. Hence, for each line of chickens, data for HVT and no HVT
groups were pooled to compare the effect of 4-TBP on MC-FT from the different lines of
chickens at 1-, 4-, 7-, and 12-weeks of age. For each time point (1-, 4-, 7- and 12-weeks of
age), multiple mean comparisons revealed that culture with 200 µM 4-TBP resulted in
higher (P < 0.05) ROS generation in SL MC-FT compared to SL-G, BL, and LBL MC-FT
cultures. ROS generation in response to 4-TBP of MC-FT from SL-G, BL, and LBL
chickens was similar at all time points except at 4 weeks of age when BL MC-FT had
higher ROS generation than SL-G and LBL (Figure 2B). Additionally, at 4 weeks, 4-TBP
stimulated ROS generation in SL and BL MC-FT was higher than at any of the other
time-points examined (Figure 2B). At 12 weeks of age several SL chickens had developed
SLV. Data for depigmented (white) SLV MC-FT exposed to 4-TBP were placed in a
separate group for the 12-week statistical analysis. Stimulated ROS generation in response
to 4-TBP was not observed in these SLV MC-FT cultures (Figure 2D).

ROS generation in SL, SL-G, and BL feather-derived MC (MC-F) and
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embryo-derived MC (MC-E) cultures in response to 4-TBP treatment

Two-way ANOVA examination of the effect of line and 4-TBP dose and their interaction
revealed a significant (P < 0.05) effect of line of chicken, dose of 4-TBP, and no line by
dose interactions on the ROS generation of MC-F in response to 4-TPB treatment.
Specifically, without 4-TBP, SL and SL-G MC-F cultures had higher ROS generation than
BL MC-F (Figure 3). Treatment with 200 µM 4-TBP resulted in increased ROS generation
by SL but not SL-G and BL MC-F. Treatment of MC-F cultures with 1000 µM 4-TBP
increased ROS generation in both SL and SL-G MC-F compared with no 4-TBP, whereby
ROS generation levels where higher in SL MC-F than SL-G MC-F (Figure 3).

Culture of MC-E with 200 µM 4-TBP resulted in higher (P < 0.05) ROS generation in SL
MC-E compared to SL-G and BL MC-E cultures, whereas, without 4-TBP, there was no
difference among MC-E cultures from BL, SL-G, and SL (Figure 4).

Morphological characteristics of MC-F and MC-E cultured with and without 4-TBP

MC dendrite retraction and aggregation at 24 h post 200 µM 4-TBP treatment was
observed in MC-F (Figure 5) and MC-E from SL chickens. Mass aggregation was also
observed in MC-F from SL chickens 24 h post 1000 µM 4-TBP treatment (Figure 5),
whereas, these 4-TBP induced alterations were less prominent in MC-F (Figure 5) and
MC-E from BL and SL-G chickens.
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Gene expression in SL, SL-G, BL and LBL MC-containing feather tissue (MC-FT)
cultures in response to 1 h treatment with 4-TBP

Two-way ANOVA conducted at each age (1-, 4-, 7- and 12-weeks) to examine the effect of
line of chicken, HVT, and line by HVT interaction on the gene-expression of various target
genes following 1 h exposure of tissues at 0 and 200 µM 4-TPB levels, revealed a
significant (P < 0.05) effect of line of chicken and no effect of HVT or line by HVT
interactions. Hence, for each line of chicken, data for HVT and no HVT groups were
pooled for one-way ANOVA to examine the effect of line, age and line by age interactions
for MC-FT cultured with 200 µM or without 4-TBP. Analysis revealed no line by age
interactions for any of the target genes analyzed. Hence, multiple means comparisons were
conducted comparing the line main effect means for each target gene expression (Figures
6-8 and Table 2-3) for each 4-TBP treatment group (0 and 200 µM).

Independent of age of chicken, there were no differences in relative MITF gene expression
in MC-FT from SL, SL-G, BL, and LBL cultured without 4-TBP for 1 h. Compared to no
4-TBP controls, treatment with 200 µM 4-TBP for 1 h resulted in lower MITF-expression
in SL-G, BL and LBL MC-FT, whereas MITF expression in SL MC-FT was not affected by
4-TBP treatment (Figure 6). The relative expression of TYR, TRP1, TRP2, BCL2, BAK1
and HSP70 expression in MC-FT from the different lines was not affected by 1 h culture
with 4-TBP, although TYR expression in LBL MC-FT cultures was higher than those from
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the other line of chickens (Table 2).

Gene expression in SL, SL-G, and BL feather-derived (MC-F) and embryo-derived
(MC-E) MC cultures in response to 1 h treatment with 4-TBP

One way ANOVA examining the effect of line on the gene-expression of various targets by
MC-F and MC-E cultured with and without 200 µM 4-TBP for 1 h revealed a significant (P
< 0.05) effect of line of chicken for both MC-F and MC-E. MC-F from SL-G and BL
chickens treated with 200 µM 4-TBP for 1 h had lower relative gene-expression levels of
MITF and TRP1 than those without 4-TBP treatment. By contrast, MITF and TRP1
expression in SL MC-F was not affected by 4-TBP treatment for 1 h (Figure 7).

Similarly, BL MC-E treated with 200 µM 4-TBP showed reduced relative expression of
MITF and TRP1 compared to no 4-TBP treatment. MITF expression in SL and SL-G
MC-E was not significantly affected by 4-TBP treatment (Fig. 8A). However, compared to
no 4-TBP cultures, expression of TRP1 was reduced in SL-G MC-E and increased in SL
MC-E (Figure 8B). For TYR, TRP2, BCL2, BAK1 and HSP70 there were no statistical
differences in gene-expression between SL, SL-G and BL MC-F and MC-E cultures with
and without 4-TBP treatment (Table 3-4).
Table 1. Primer1 and probe1,2 sequences used to examine the relative expression of target
genes
Target Primer/probe Sequences (5' to 3')
28S Forward
GGCGAAGCCAGAGGAAACT
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Accession NO.
X59733

Reverse
Probe
TYR Forward
Reverse
Probe
TRP1 Forward
Reverse
Probe
TRP2 Forward
Reverse
Probe
MITF Forward
Reverse
Probe
HSP70 Forward
Reverse
Probe
BCL2 Forward
Reverse
Probe
BAK1 Forward
Reverse
Probe
1

GACGACCGATTTGCACGTC
AGGACCGCTACGGACCTCCACCA
ATAATGCCCTTCACATCTACATGAAT
GCTCAAAAATGCTGTCAACAAATG
CTCAATGTCCCAAGTACAAGGCTCTGCG
GGAACCATTTGTAACAGCACTGAAG
CCATAGGCCGTGCAACATTT
CGGTCCCATCCGTAGAAATCCTGCTG
CCTTTCCCGGCATGAGTTT
AGCGCATTCCTGAAGCTGAA
CAGTCCTCCGTTTTTCCGCAATTCCA
AAGAACTGGGCACCTTGATACC
GATGTAGTCCACTGATGCTTTTAGAATAG
AAATCAAACGACCCGGATATGCGCTG
GACTGCTCTCATCAAGCGTAACA
TCATACACCTGGACGAGGACACT
CACCATTCCCACCAAACAAACACAGACC
GCGTCAACCGGGAGATGT
GGTTCAGGTACTCGGTCATCCA
CCGCTGGTGGACAACATTGCCA
CCCTGCTGGGTTTCGGTTA
CGCAGGAAGCCCGTGAT
TGCATGGCCATCCACGTCTACCAG

NM_204160.1

NM_205045.1

NM_204935.1

NM_205029.1

FJ217667.1

NM_205339.1

NM_001030920.1

Primer and probe oligos were synthesized by MWG Biotech, Hight Point, NC.

2

Probes had FAM (6-carboxyfluorescein) at 5’ end and TAMRA
(6-carboxytetramethylrhodamine) at 3’ end.
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Table 2. Relative expression1 of target genes from MC-FT not affected by 4-TBP at 1 h
co-culture2
Gene

SL

SL-G

BL

LBL

TYR

1.08 ± 0.05a

1.12 ± 0.07a

1.06 ± 0.05a

1.30 ± 0.05b

TRP1

0.89 ± 0.08

0.82 ± 0.18

0.87 ± 0.11

0.98 ± 0.18

TPR2

2.09 ± 0.18

1.78 ± 0.23

1.64 ± 0.68

2.24 ± 0.19

BCL2

1.89 ± 0.28

2.12 ± 0.32

1.98 ± 0.26

2.01 ± 0.26

BAK1

1.15 ± 0.14

1.14 ± 0.15

1.13 ± 0.09

0.96 ± 0.18

HSP70

0.81 ± 0.25

1.41 ± 0.32

1.38 ± 0.18

1.72 ± 0.68

1

Relative expression of target genes was calculated by the delta delta Ct method of data
obtained by qRT-PCR, where 28S served as endogenous control gene and a pool of cDNA
from feathers of age-matched parental line BL chickens were used as the calibrator sample.
Data were analyzed by fit model of the JMP Pro 9 software and were shown as mean ±
SEM.
2

Due to the absence of interactions between the effects of the line of chickens and 4-TBP
treatment, data on gene expression were pooled across treatment. Only the main effects of
type of chicken are shown.
a,b

For each target gene, means without a common letter are significantly different (P <
0.05).
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Table 3. Relative expression1 of target genes in feather-derived MCs that were not affected
by 4-TBP treatment for 1 h2
Gene

SL

SL-G

BL

TYR

1.87 ± 0.15

2.09 ± 0.21

2.16 ± 0.12

TPR2

1.10 ± 0.22

0.88 ± 0.29

0.91 ± 0.11

BCL2

0.89 ± 0.28

1.10 ± 0.12

1.08 ± 0.31

BAK1

1.02 ± 0.09

1.03 ± 0.11

1.05 ± 0.12

HSP70

0.91 ± 0.24

1.21 ± 0.22

1.07 ± 0.21

1

Relative expression of target genes was calculated by the delta delta Ct method of data
obtained by qRT-PCR, where 28S served as endogenous control gene and a pool of cDNA
from BL feather-derived MCs was used as the calibrator sample. Data were analyzed by fit
model of the JMP Pro 9 software and were shown as mean ± SEM.
2

Due to the absence of interactions between the effects of the line of chickens and 4-TBP
treatment, data on gene expression were pooled across treatment. Only the main effects of
type of chicken are shown.

74

Table 4. Relative expression1 of target genes in embryo-derived MCs that were not
affected by 4-TBP treatment for 1 h2
Gene

SL

SL-G

BL

TYR

3.18 ± 0.21

2.92 ± 0.19

3.29 ± 0.35

TPR2

3.24 ± 0.16

3.54 ± 0.23

3.45 ± 0.45

BCL2

2.98 ± 0.27

2.73 ± 0.26

2.98 ± 0.34

BAK1

2.24 ± 0.34

2.56 ± 0.12

2.64 ± 0.24

HSP70

3.89 ± 0.59

4.56 ± 0.46

4.24 ± 0.34

1

Relative expression of target genes was calculated by the delta delta Ct method of data
obtained by qRT-PCR, where 28S served as endogenous control gene and a pool of cDNA
from BL embryo-derived MCs was used as the calibrator sample. Data were analyzed by fit
model of the JMP Pro 9 software and were shown as mean ± SEM.
2

Due to the absence of interactions between the effects of the line of chickens and 4-TBP
treatment, data on gene expression were pooled across treatment. Only the main effects of
type of chicken are shown.
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Figure 1. Autoimmune chicken model for human vitiligo and morphology of growing
feathers from pigmented SL chicken. A) Brown line (BL) parental control (< 1% vitiligo),
B) Smyth line (SL) chicken with vitiligo (loss of feather pigmentation due to loss of
melanocytes (MCs) in the feather), and C) Light Brown Leghorn (LBL) vitiligo-resistant
control. Together, these lines of chicken constitute an excellent animal model to study
vitiligo. D) Illustration of dermal (grey) pigmentation in shanks from SL-G chickens (<5%
vitiligo); bottom: the grey shanks of a SL-G chicken; top: normal shank color of a SL
chicken. E) Normally pigmented growing feathers at one side of breast track from SL
chickens. Pigmented growing feathers collected from SL chickens showed the living part
(feather tip) of growing feathers (from the newest growth to the epidermal cap) and the
bottom 3 mm of the newest growth of growing feathers (MC-FT). F) Micro-structure of the
newest growth of a MC-FT with normal pigmentation. Longitudinal, unstained, frozen
sections examined at 50 x original magnification under a bright-field microscope.
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Figure 2. Relative ROS generation in response to 4-TBP treatment of
melanocyte-containing feather tissue (MC-FT) cultures. Growing feather were collected
from non-HVT-/HVT-injected SL (N = 10), SL-G (N = 6), BL (N = 10), and LBL (N = 10)
chickens when the chickens were A) 1-, B) 4-, C) 7- and D) 12-weeks of age. The MC-FT
were cultured without or with 200 µM 4-TBP for 1 h. After the incubation, 20 µL of
2',7'-DCF-DA was added and ROS production measured over 90 min period. There was no
difference in ROS production by tissues from HVT-positive and HVT-negative chickens
and data pooled across HVT treatment are shown. Data shown are the mean ± SEM of the
slope of ROS generation (fluorescence units/min; f.u.) due to 4-TPB treatment (ROS
treated – ROS untreated). SL = Smyth line, SL-G = SL with grey shanks), BL = Brown line,
LBL = Light Brown Leghorn and SL vit = SL with vitiligo chickens. a,b,c Means without a
common letter are significantly different (P < 0.05).
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Figure 3. Relative ROS generation in SL, SL-G, and BL feather-derived melanocytes
(MC-F) cultured with and without 4-TBP. MC-F cultures were prepared from grwoing
feathers of 10 SL, 6 SL-G, and 6 BL 12-week-old chickens following a modified procedure
(Boissy et al., 1987). MC-F cultures (4th or 5th passage) were deprived of TPA prior to
treatment with 0, 200 and 1000 µM 4-TBP. The generation of ROS was determined using
2',7'-dichloro-fluorescein diacetate (2',7'-DCF-DA) after 1 hour incubation of 1 x 104 cells
with 4-TBP treatment at 40.5°C humidified incubator with 5% CO 2 . ROS generation for
each sample is expressed as the slope of fluorescence units over time. Each histogram
represents the mean ± SEM ROS generation for each line of chicken. a,b,c,d For each line of
chicken, means without a common letter are significantly different (P < 0.05).
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Figure 4. Relative ROS generation by embryo-derived SL, SL-G, and BL MC cultured
with and without 4 TBP. MC-E cultures were prepared from 10 SL, 6 SL-G, 6 BL 72 h
embryos following a modified method based on Boissy and Halaban (1985).
Feather-derived MC cultures (4th or 5th passage) were deprived of TPA and cholera toxin
prior to treatment with 4-TBP. The generation of ROS was determined using
2',7'-dichloro-fluorescein diacetate (2',7'-DCF-DA). Fluorescence generated by 1 x 104
cells was determined every 10 min over a 90 min period. ROS generation for each sample
was expressed as the slope of fluorescence units/min. Each histogram represents the mean
± SEM ROS generation for each line. a,b Means within a type of chicken without a common
letter are significantly different (P < 0.05).
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Figure 5. Effects of 4-TBP treatment on the morphology of feather-derived melanocyte
(MC-F) cultures. MC-F from vitiligo-prone Smyth line (SL and BL chickens were cultured
(1 x 104 cells/well; 96 well culture plates) in RPMI 1640 medium w/o phenol red for 24 h.
After acclimation to the medium, cells were subjected to 4-TBP treatment (0, 200 or 1000
µM 4-TBP). Morphology of MCs viewed at a) 100x; b) 400x magnification using a
bright-field inverted microscope following 3 h of 4-TBP treatment.
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Figure 6. Relative gene expression of MITF in melanocyte containing feather tissue
(MC-FT) cultured with and without 4-TBP for 1 h from SL, SL-G, and BL chickens.
Growing feather were collected from non-HVT-/HVT-injected SL and SL-G, BL, and LBL
control chickens (N = 10/line/HVT group) when the chickens were 1-, 4-, 7-, 12-weeks of
age. The MC-FT were cultured without or with 200 µM 4-TBP for 1 h. MITF expression
was not affected by HVT status or age of chicken; hence, data were pooled within a type of
chicken. Relative expression was determined by the delta delta Ct method in which a pool
of cDNA from BL MC-FT (untreated) was used as the calibrator sample and 28S was used
as the endogenous control in the qPCR. Data shown are the main effect mean ± SEM for
each type of chicken. a,b Means without a common letter are significantly different between
control and treatment from each chicken line (P < 0.05).
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Figure 7. Relative gene expression of A) MITF and B) TRP1 in SL, SL-G, and BL feather
derived melanocytes (MC-F) cultured with and without 4-TBP for 1 h. MC-F cultures were
prepared from growing feathers of 12-week-old SL (10), SL-G (6), BL(6) chickens
following a modified MC culture procedure (Boissy et al., 1987). MC-F cultures (4th or 5th
passage) were deprived of TPA prior to 4-TBP. Relative target gene expression was
determined by the delta delta Ct method in which a pool of cDNA from BL MC-F
(untreated) was used as the calibrator sample and 28S was used as the endogenous control
in the qPCR. Data shown are the mean ± SEM. a,b Means without a common letter are
significantly different between control and treatment from each chicken line (P < 0.05).
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Figure 8. Relative gene expression of A) MITF and B) TRP1 in SL, SL-G, and BL
embryo-derived melanocytes (MC-E) cultured with and without 4-TBP for 1 h. MC-E
cultures were prepared from 10 SL, 6 SL-G, 6 BL 72 h embryos following a modified
method based on Boissy and Halaban (1985). Feather-derived MC cultures (4th or 5th
passage) were deprived of TPA and cholera toxin prior to treatment with 4-TBP. Relative
target gene expression was determined by the delta delta Ct method in which a pool of
cDNA from BL MC-E (untreated) was used as the calibrator sample and 28S was used as
the endogenous control in the qPCR. Data shown are the mean ± SEM. a,b,c Means without
a common letter are significantly different between control and treatment from each
chicken line (P < 0.05).

88

Discussion

Phenol derivative compounds, like 4-TBP, have been shown to induce vitiligo in
susceptible individuals. In vitro studies on the effect of 4-TBP on MC from healthy donors
and vitiligo patients showed that incubation with 4-TBP altered antioxidant levels,
including catalase, GSH and superoxide dismutase, and resulted in lipid peroxidation
(Koca et al., 2004). Manga et al. (2006) demonstrated that 4-TBP induces oxidative stress
that is more readily overcome by MCs from normally pigmented individuals than from
individuals with vitiligo. 4-TBP is oxidized by tyrosinase to quinones
(Thorneby-Andersson et al., 2000), which cause futile redox cycling and cytotoxic levels
of hydrogen peroxide and glutathione disulfide (GSSG), and hence oxidative stress
(O'Brien, 1992). Based on these reports, the ability of MC to respond to oxidative stress
may play a role in the etiology of vitiligo.

SL chickens exhibits a genetic predisposition to the development of vitiligo (SLV).
Comparison of the response of SL MC to 4-TBP in the current study, revealed that 4-TBP
induced higher levels of ROS generation, and hence oxidative stress, in MC-FT from
susceptible SL chickens compared to SL-G, BL and LBL MC-FT (Figure 1 and 2). Similar
results were also observed in MC-F and MC-E cultures stimulated with 4-TBP (Figure 3
and 4). These observations support our hypothesis that, like vitiligo-susceptible humans
(Manga et al., 2006), the vitiligo-susceptible SL chickens are more sensitive to 4-TBP and,
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like in humans, this heightened sensitivity to 4-TBP induced oxidative stress may be due to
depletion of the GSH antioxidant system (Thorneby-Andersson et al., 2000; O'Brien,
1992).

In the current study, an important confirmation of MC-specific effects of 4-TBP in
chickens was the lack of 4-TBP stimulation of ROS generation in white (no MC) feather
tips from vitiliginous SL chickens (Figure 2D). Additionally, the observation that 4-TBP
treatment of MC-FT from SL chickens with grey shanks (SL-G), which do not develop
vitiligo, resulted in similarly low ROS production as that observed in BL and LBL controls
strongly supports association between SL vitiligo-susceptibility and heightened 4-TBP
sensitivity (Figure 2, 3 and 4). The grey shanks in SL-G chickens are due to the Id dermal
pigmentation gene. This is a sex-linked recessive gene where Id+ females, Id+Id+ males
and Id+id+ males will have yellow shanks, and id+ females and id+id+ males will have grey
shanks. SLV is rarely observed in SL-G, even if SLV develops aggressively in their Id+ SL
siblings. How id+/id+id+ genotype exerts its protective effects regarding SLV expression
needs to be further examined. Based on the ROS and gene-expression studies it appears
that MC in SL-G chickens are more robust and better able to cope of the effects of 4-TBP
exposure. Another important finding of the current study was that HVT infection, a known
environmental trigger of SLV expression in susceptible SL chickens, did not influence the
effects of 4-TBP on MCs in MC-FT collected from HVT vaccinated chickens. This may
due to the direct effect of 4-TBP on MCs compared to a likely bystander effect of HVT in
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the feather.

In addition to altered ability of SL MC to cope with oxidative stress, results from the
current study on the effects of 4-TBP on SL MC also revealed morphological changes in
MC-F and MC-E in the presence of 4-TBP and ROS. These changes included
morphological abnormalities such as dendrite retraction and mass aggregation in SL MC,
which were less prominent in BL MC cultures (Figure 5). SLV susceptibility of SL
chickens was previously shown to be manifested in part by an inherent MC defect.
Abnormally-shaped melanosomes could be observed in SL MCs before SLV using
transmission electron microscopy. These altered melanosomes were not observed in MCs
from the parental Brown line (BL) control (Boissy et al., 1983). MC-E from SL chickens
also exhibited abnormalities such as fewer dendrites and selective autophagocytosis of
melanosomes as compared to cultured MC-E from BL and LBL controls (Boissy et al.,
1986). In the current study, the observed higher level of ROS accumulation in SL MC-E
cultures compared to those derived from SL-G and BL embryos further emphasizes that
these altered responses of SL MC are inherent and not induced by differentiation in the
feather environment of SL chickens (Figure 4).

Studies on human melanocytes have shown that melanogenic proteins are involved in the
response to 4-TBP treatment. 4-TBP, as a substance, is metabolized by TYR in MCs (Yang
and Boissy, 1999). MITF, which is master regulator for both MC proliferation and melanin
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synthesis, was shown to be down regulated in response to oxidative stress
(Jimenez-Cervantes et al., 2001). 4-TBP-induced cytotoxicity in human vitiligo MC was
associated with increased expression levels of MITF and TRP1 (Manga et al., 2006). In our
study, MITF-expression was down-regulated in MC-FT, MC-F, and MC-E cultures from
control SL-G and BL chickens within 1 h exposure to 4-TBP. This drop in MITF was
accompanied by a drop in TRP1 expression in MC-F and MC-E cultures. In SL MC-FT,
MC-F, and MC-E cultures these alterations in MITF were not observed and TRP1
expression was increased in MC-F and MC-E cultures (Figure 7 and 8). The divergent
response in control and SL MC regarding MITF- and TRP1-expression are in line with
those in humans, suggesting that lower expression of these proteins may play a similarly
protective role in chicken MCs during 4-TBP exposure. How MITF and its downstream
product TRP1 influence the sensitivity of SL MC to 4-TBP is not well understood. MITF
also regulates the anti-apoptotic factor BCL2 (McGill et al., 2002) to induce apoptosis in
response to 4-TBP (Hariharan et al., 2010). BCL2 has been identified as an MITF target
gene and has been shown to be partially important for cell rescue from oxidative
stress-induced apoptosis in MITF-depleted cells (Yajima et al., 2011). Previous study also
indicated human pro-apoptosis gene BAK1 and cellular stress related protein HSP70 have
potential effects in the response to 4-TBP (Kroll et al., 2005). However, in the current study
there were no statistical differences in BCL2, BAK1 and HSP70 expression in MC-FT,
MC-F, and MC-E after 1 h of 4-TBP treatment (Table 2-4). A longer exposure time of SL,
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BL and LBL MC to 4-TBP would have provided more insight into protective response
mechanisms initiated in MC during 4-TBP exposure.

The current study clearly showed that MCs from vitiligo-prone SL chickens, like those
form vitiligo patients, are inherently more sensitive to 4-TBP treatment than MCs from
SL-G, BL and LBL chickens. Exposure to 4-TBP induced oxidative stress in MCs, which
in SL-G, BL, and LBL control MC triggered down-regulation of MITF and TRP1
expression and possibly other genes that may allow MC to cope and control the oxidative
stress. Whereas, these protective responses to 4-TBP in the inherently abnormal MCs from
SL chickens were not effectively initiated. In addition to altered antioxidant capacity in SL
chickens (Wijesekera, 2004), the reduced ability of SL-MC to withstand oxidative stress
may be due in part to a disruption in the regulation of MITF and TRP1 expression.
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CHAPTER III
ALTERATIONS IN MELANOCYTE MORPHOLOGY, GENE-EXPRESSION AND
ROS GENERATION IN GROWING FEATHERS FROM AUTOIMMUNE
VITILIGO-PRONE SMYTH LINE CHICKENS TREATED WITH 4-TERTIARY
BUTYL PHENOL IN VIVO
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4-TBP: 4-tertiary butyl phenol; α-MSH: α-melanocyte-stimulating hormone; BAK1:
BCL2-antagonist/killer 1; BCL2: B-cell lymphoma 2; BL: Brown line; GSH: glutathione;
HVT: turkey herpesvirus; IL: interleukin; LBL: Light Brown Leghorn; MC: melanocyte;
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MCHR1: melanin-concentrating hormone receptor 1; MITF: microphthalmia-associated
transcription factor; ROS: reactive oxygen species; SL: Smyth line; SLV: Smyth line
vitiligo; qRT-PCR: quantitative reverse transcription-polymerase chain reaction; TRP1:
tyrosinase-related protein 1; TRP2: tyrosinase-related protein 2; TYR: tyrosinase.
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Abstract

Smyth line (SL) chicken is an animal model for human autoimmune vitiligo. SL vitiligo
(SLV) is characterized by spontaneous, post-hatch autoimmune loss of melanocyte (MC)
resulting in feather depigmentation. In both chickens and humans, multiple factors
contribute to the loss of MCs and development of vitiligo, including genetic susceptibility,
immune system involvement and environmental triggers. In humans, phenolic derivatives,
such as 4-tertiary butyl phenol (4-TBP), have been shown to trigger vitiligo in susceptible
individuals. Recent studies also have shown heightened sensitivity of SL MCs to 4-TBP in
vitro (Chapter II). In order to examine the effects of 4-TBP on SL MC in vivo, leukocyte
infiltration, morphology of MCs, and gene expression were monitored in pigmented
growing feathers injected with10 µL 4-TBP (0.15 mg/mL) into the pulp. Feathers were
collected before (0 h) and at 1-, 3.5-, 6-, and 72-h post-4-TBP injection from
eight-week-old SL, Brown line (BL, parental control, < 1% vitiligo) and Light Brown
Leghorn (LBL, vitiligo resistant) chickens. Leukocyte infiltration post-4-TBP injection
was elevated in SL compared to BL and LBL feathers. 4-TBP injection into SL growing
feathers resulted in MC detachment and dendrite retraction at 1 h and 3.5 h post-injection.
By 6 h these alterations were less prominent and normal MC morphology was restored 3 d
after 4-TBP injection. For BL and LBL chickens, MC morphology was not affected by
4-TBP injection into growing feathers. Gene expression analysis revealed a drop in the
expression of microphthalmia-associated transcription factor (MITF) following 4-TBP
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injection. In SL feathers this decrease in MITF expression was much less prominent than in
BL and LBL feathers and returned to pre-injection level by 6 h. However, at 3 d post
injection, MITF levels where similarly low in injected feathers from all chickens. In SL
feathers, tyrosinase related protein (TRP) 1 and TRP2 expression was elevated at 6 h
compared to pre-injection levels and to BL and LBL samples. The expression of
anti-apoptotic B-cell lymphoma 2 (BCL2) was lower in SL feathers by 6 h and 3 d
compared to pre-injection levels , whereas BCL2 in samples from BL and LBL controls
were elevated at 3 d compared to pre-injection levels and were higher than in SL samples at
all times post-4TBP injection. At 1 h post-4-TBP injection, heat shock protein (HSP) 70
expression levels were higher in BL and LBL compared to SL feathers, reached peak levels
at 6 h and remained elevated at 3 d. HSP70 levels in SL were not affected by 4-TBP. These
different responses of vitiligo-prone SL and controls to in vivo administration of 4-TBP
into melanocyte-containing feather tissue, further emphasize the heightened sensitivity of
SL MC to 4-TBP which may be related to heightened TRP 1 expression. The reduction in
MITF and increase in HSP70 and BCL2 observed in control samples may be a protective
response to 4-TBP induced cellular stress.
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Introduction

Vitiligo is an acquired pigmentary disorder characterized by loss of epidermal melanocytes
(Lerner, 1978) which results in patches of depigmentation, and in some patients, complete
depigmentation of the skin and its derivatives (Ortonne, 1993). This disorder is found in
0.1 - 2 % of the world’s human population. Although the etiopathological mechanisms of
vitiligo are not well understood, it is believed that many factors contribute to vitiligo
development including both genetic and non-genetic factors (Reza et al., 2011). Oxidative
stress has been shown to play a role in various clinical disorders. The exact role of
oxidative stress in vitiligo is unclear, but it is assumed to play a part in either the
development of the disorder or the progressive loss of MCs (Jian et al., 2011). Phenolic
derivatives, such as 4-tertiary butyl phenol (4-TBP), have been shown to trigger vitiligo in
susceptible individuals. Manga et al. (2006) demonstrated that 4-TBP induces oxidative
stress that was more readily overcome by MCs from normally pigmented individuals than
from individuals with vitiligo. 4-TBP is structurally similar to tyrosine, the initial substrate
in melanogenesis that is oxidized by tyrosinase (Yang and Boissy, 1999). The oxidation of
4-TBP yields a toxic intermediate called quinone that further reacts with cysteine or
glutathione (GSH) to produce 4-tert-butyl-6-S-cysteinylcatechol and
4-tert-butyl-6-S-glutathionylcatechol, respectively (Kirsten et al., 2000). The oxidation of
4-TBP in MCs results in the generation of reactive oxygen species (ROS). In addition,
GSH, an antioxidant, helps to protect cells from ROS, such as free radicals and peroxides.
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The loss of GSH reduces the ability of cells to overcome oxidative stress. However, the
exact role of oxidative stress induced by 4-TBP in vitiligo is currently unclear.

Previously, it has been shown that human MCs cultured in the presence of 4-TBP
experience dose-dependent apoptosis (Manga, 2006) and the percentage of cells that die
following exposure to 4-TBP can be significantly reduced by excluding
α-melanocyte-stimulating hormone (α-MSH; Yang et al., 1999). α-MSH is a key
physiologic inducer of melanogenesis. The biological function of α-MSH is mediated
through its binding to MC1R, the only melanocortin receptor expressed in MCs (Pavey
and Gabrielli, 2002). MC1R is a G protein-coupled receptor that activates adenylate
cyclase. The increased intracellular concentration of cAMP mediates the expression of
the MC-specific isoform of the microphthalmia-associated transcription factor (MITF;
Widlund and Fisher, 2003). MITF in turn activates the expression of many downstream
genes, including tyrosinase (TYR), tyrosinase-related protein 1 (TRP1) and TRP2,
needed for melanogenesis.

Although MITF is an important factor in MC development, survival, and differentiation,
recent studies also have shown that MITF is a substrate of caspases and plays a key role
in the apoptosis of melanoma cells (Larribere et al., 2005). Over-expression of BCL2 has
been shown to overcome the melanocyte apoptosis triggered by disruption of MITF
(McGill et al., 2002). In addition, MITF regulates endogenous levels of BCL2 in MCs.
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Thus, BCL2 expression is very critical for MC survival and may prevent apoptosis during
cellular stress, such as 4-TBP related oxidative stress. Furthermore, exposure of the
human MC immortalized vitiligo cell line (PIG3V) to 4-TBP resulted in elevated
extracellular levels of heat shock protein (HSP) 70 and activation of dendritic cell (DC)
effector functions focused on the stressed MCs (Kroll et al., 2005).

The Smyth line (SL) of chickens is a well established animal model for the study of
spontaneous development of autoimmune vitiligo, displaying all the characteristics of the
human disorder (Smyth, 1981 and 1989; Wick et al., 2006; Erf, 2010). Like human vitiligo,
SL vitiligo (SLV) is a multifactorial disorder involving genetic susceptibility,
environmental triggers, and cellular as well as humoral immune system components in the
progressive loss of MCs. Under conventional rearing conditions, including routine
administration of turkey herpesvirus (HVT) at hatch, approximately 80 - 95 % of SL
chickens develop SLV between 6 - 20 weeks of age. Without the HVT environmental
trigger, the incidence of SLV is reduced to < 20% (Erf et al., 2001). SL chickens together
with the MHC-matched Brown line (BL) parental control (< 1% vitiligo) and the Light
Brown Leghorn (LBL) vitiligo-resistant control chickens constitute an excellent animal
model to study vitiligo. Another excellent attribute of the SL chicken model for vitiligo
study is the location of MCs in the growing feathers, rather than the skin (Figure 1).
Growing feathers are easily and repeatedly accessible for sampling, providing unique
opportunity to examine the evolving lesion prior to and throughout the development of
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SLV in the same individuals.

Recent in vitro studies have shown a heightened sensitivity of SL MC to 4-TBP (Chapter
II). Additionally, based on the divergent ROS and MITF- and TRP1-expression response to
a 1 h 4-TBP exposure in SL MC versus BL- and LBL-MC, it appears that aberrant
regulation of these melanogenesis-related proteins may be related to the reduced ability of
SL MC to withstand oxidative stress. Specifically, the culture of MC-containing feather
tissue, feather-derived MC or embryo-derived MC with 4-TBP resulted in higher ROS
generation in SL compared to BL and LBL MCs. The elevated ROS accumulation in SL
MC was accompanied by increased RNA expression levels of TRP1 in feather- and
embryo-derived MC. On the other hand, the low levels of 4-TBP induced ROS generation
in BL and LBL MC cultures were associated with a decrease in MITF and TRP1 expression
levels. The expression of TYR, TRP2, BCL2, BAK1 and HSP70 was however not affected
by in vitro 4-TBP treatment of MC for 1 h in SL and controls. In the current study, we will
explore the effects of 4-TPB on SL and control MC in situ by in vivo administration of
4-TBP into the pulp of melanocyte-containing growing feathers. By injecting multiple
growing feathers in the same individual, injected feathers can be collected for ex vivo
analysis at various times post-4-TBP injection to monitor the local in vivo effects of 4-TPB.
To assess the in vivo effects of 4-TBP in the feather, MC morphology, leukocyte infiltration,
and expression of HSP70 as well as melanogenesis- and apoptosis-related genes will be
examined before and at various times post-4-TBP injection (0, 1, 3.5, 6, and 72 h). We
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hypothesize, that similar to in vitro observations, SL MC will have heightened sensitivity
to 4-TBP in vivo compared to BL and LBL melanocytes. Characterization of these
activities in the vitiligo-prone SL, parental BL and vitiligo-resistant LBL chickens will
provide important insight into the underlying MC defect and etiology of vitiligo.
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Materials and Methods

Experimental Animal

Three lines of MHC-matched (B101/101) chickens were used for this study: 1) the
vitiligo-prone SL chickens which exhibit an 80 - 95% incidence of SLV by 20 weeks of age
under conventional rearing conditions, 2) the parental BL (< 1% incidence of vitiligo)
control chickens, and 3) the vitiligo-resistant LBL (no incidence of vitiligo) control line of
chickens (Erf, 2010). On the day of hatch, chicks from each pedigreed family were tagged
using a color coded numbering system. Chicks were not vaccinated with live herpesvirus
of turkey, a known environmental trigger of SLV expression in susceptible individuals (Erf
et al, 2001). All chicks were reared in floor pens on wood-shavings litter in a
HEPA-filtered room in the University of Arkansas Poultry Health Laboratory. Using these
rearing conditions the incidence of SLV has repeatedly been shown to be < 10% (Erf,
personal communication). Food and water were available ad libitum. Standard diet,
temperature and lighting protocols were followed and the well-being of chicks was
checked daily. All procedures for this study were approved by the Institutional Animal
Care and Use Committee (IACUC) Protocol #08011.

Feather Injection Study

At eight weeks of age, melanocyte-containing growing feathers of 10 SL, 5 BL, and 5 LBL
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chickens were injected with 4-TBP. Specifically, 10 µL of 0.15 mg/mL (1mM) 4-TBP
(Sigma-Aldrich Inc., St. Louis, MO, USA) were injected into the pulp of 8 growing
feathers on each breast track from each bird using insulin syringes with the BD
Ultra-FineTM needle (Capacity: 3/10cc,30 unit; Length: 8 mm; Gauge: 31 G; NDC/HRI#
08290-8438-01, Becton, Dickinson and Company). Prior to injection, emerging barbes of
the growing feathers were cut, leaving the epidermal cap surrounding the pulp (dermis)
intact. This approach made it easier to inject into the center of the pulp and allowed for
identification of injected feathers at collection time. Three samples of feathers (feather tips)
were collected before (0 h) and at 1-, 3.5-, 6- and 72-h post-4-TBP injection. At each time
point, one feather tip was placed into 10% buffered formalin for conventional histology
and two feather tips were snap frozen in liquid N 2 and stored at -84oC for later RNA
analysis. Based on previous studies, feather pulp injection with vehicle alone does not
cause alteration in this tissue; hence, this control was not included in this study (Erf et al.,
2007).

Assessment of leukocyte infiltration and MC morphology

Formalin fixed, processed, and paraffin embedded feather samples were cut into
longitudinal sections (6 μm thick) and stained with Hematoxylin/Eosin stain. Using a
bright-field microscope at 50x magnification and a 10 x 10 mm ocular inserted (1 square),
the extent of leukocyte infiltration was determined based on the percentage of affected pulp
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area and on the cell density of infiltration. Area scores ranging from one to five were
assigned depending on the percentage area affected by leukocyte infiltration: <20% (score
1); >20%,<40% (score 2); >40%,<60% (score 3); >60%,<80% (score 4); and >80%,<100%
(score 5). Density scores ranging from zero to three were given depending on the number
of leukocytes/square with 0-20 cells, 20-100 cells, 100-150 cells, and >150 cells receiving
score 0 to 3, respectively. The morphological assessments of melanocyte and the nature of
the leukocyte infiltrate [granulocytes and mononuclear cells (lymphocytes and
monocytes/macrophages)] were carried out under a bright field microscope (100x, 400x
and 1000x magnification).

RNA extraction, quantification, and cDNA synthesis

Total RNA was isolated from the 3 mm newest growth of the snap frozen feather tips which
contains the epidermal tissue where MCs are located. RNA was isolated using the
RNeasy® Mini Kit (Qiagen, Valencia, CA) and following the protocol for “Purification of
Total RNA from Animal Tissues” with modifications. MC-F were homogenized by Tissue
Tearor (BioSpec Products, Bartlesville, OK, Model: 985370-395) provided in the kit. Total
RNA was isolated from homogenates with on-column DNA digestion (Qiagen). RNA was
eluted in 30 µL RNase-, DNase-free water and stored at -80°C until use. RNA quality and
quantity were determined by ExperionTM RNA StandardSens Reagents and Supplies
(Bio-Rad Laboratories, Hercules, CA) following manufacturer’s instructions (Figure 5).
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RNA (175 ng) was reverse transcribed into cDNA by High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Foster City, CA) in a 10 μL reaction volume
according to manufacturer’s instruction. A Biometra® personal cycler (Biomedizinische
Analytik GmbH, Germany) was programmed as follows: 25ºC for 10 min, 37ºC for 2 h,
85ºC for 5 min and 4ºC holding temperature. Then cDNA was stored at -80ºC until
further analysis.

Taqman® quantitative PCR (qPCR)

qPCR was performed on the cDNA samples (Primer and probes are shown in Table 2) in 25
μL reaction volume on a ABI PRISM 7300 sequence detection system (Applied
Biosystems, Foster City, CA) using the Universal PCR Master Mix (Applied Biosystems,
Foster City, CA) and following manufacturer’s instruction. In each plate, a calibrator
sample (a pool of cDNA from feather tips of age-matched BL birds), a non-template
control, and sample cDNA were included. 28S ribosomal RNA was the endogenous control
gene. Cycling profiles used were 94ºC for 15 min, and 50 cycles of denaturation at 94ºC for
60 s, and annealing/extension at 60ºC for 60 s. The relative gene expression was
determined by the delta delta Ct (∆∆Ct) method (Wong and Medrano, 2005).

Statistical Analysis

Statistical analysis was carried out using JMP Pro 9 (JMP Software Inc., Cary, NC).

111

Two-way ANOVA was used to examine the effects of line of chicken (SL, BL, and LBL),
time (0-, 1-, 3.5-, 6- and 72-h), and line by time interactions, on the expression of each
target gene and area and density of leukocyte infiltration. In the presence of significant
main effects for line and/or time, and the absence of line by time interactions, Fisher’s LSD
multiple means comparison was used to determine differences among group means. P
values ≤ 0.05 were considered significant. Data were reported as means ± SEM.
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Results

Mononuclear cell infiltration into the pulp of 4-TBP injected growing feathers

4-TPB injection resulted in mononuclear cell (lymphocytes and macrophages) infiltration
into the feather pulp (Figure 2). In terms of area score, 2.5 fold increase (P < 0.05) in
mononuclear cell infiltration could be observed in SL feathers at 1, 3.5, and 6 h post-4-TBP
injection compared to pre-injection levels. By 3d post-4-TBP injection leukocyte
infiltration was near pre-injection levels. Compared to pre-4-TBP treatment levels,
mononuclear cell infiltration in BL feathers increased 2 fold (P < 0.05) at 1, 3.5 and 6 h and
returned to pre-injection levels at 3 d. The extent of mononuclear cell infiltration in LBL
feathers was nearly identical to that observed in BL feathers except that pre-injection levels
were already restored at 6 h post-4-TBP injection. Generally, mononuclear cell infiltration
area scores tended to be higher in SL than in BL and LBL feathers, with higher (P < 0.05)
levels observed at 3.5 h and 6 h post-4-TBP treatment compared to BL and LBL feathers,
respectively (Figure 3A).

Infiltration density scores were not different in 4-TBP injected SL, BL and LBL feathers.
Compared to pre-4-TBP injection levels, the density scores for SL, BL and LBL chickens
were elevated (P < 0.05) at 1 h, remained at this level at 3.5 and 6 h and returned to
pre-4-TBP injection levels by 3 d post-4-TBP treatment (Figure 3B).
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Melanocyte morphology in 4-TPB injected growing feathers

In SL chickens, injection of 4-TBP into the pulp of growing feathers resulted in MC
detachment and dendrite retraction at 1 and 3.5 h post-injection. By 6 h these alterations
were less prominent and normal MC morphology was restored 3 d after 4-TBP injection.
These 4-TBP induced morphological alterations in SL MC were not observed in BL and
LBL injected feathers (Figure 4).

Expression of target genes in 4-TBP injected growing feathers

Compared to pre-injection levels, the relative gene expression of MITF in SL feathers
dropped slightly at 1 and 3.5 h (P < 0.05), increased significantly at 6 h and dropped (P <
0.05) below pre-injection levels at 3 d after 4-TBP treatment. By comparison, in BL and
LBL feathers, MITF expression levels dropped substantially (P < 0.05) below pre-injection
levels within 1 h and remained at this low level throughout the 3 d sampling period (Figure
6A). Compared to BL and LBL controls, MITF gene expression levels were higher in SL
feathers at 1, 3.5, and 6 h, but lower at 3 d (Figure 6A).

Compared to pre-injection levels, the relative TRP1 expression in SL feathers increased
significantly (P < 0.05) at 6 h and returned to pre-injection level at 3 d post-4-TBP
treatment. In comparison, the level of TRP1 expression in BL and LBL dropped (P < 0.05)
below pre-injection levels at 1 h, stayed at this level for the 3.5 h and 6 h time points, and
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returned to pre-injection levels at 3 d (Figure 6B). TRP1 gene expression levels were
higher in SL feathers compared to BL and LBL controls at all time-points post-4-TBP
injection (Figure 6B).

The relative expression of TRP2 in SL feathers increased (P < 0.05) starting at 3.5 h
post-4-TBP injection, reached peak levels at 6 h, and remained elevated at 3 d, whereas
TRP2 expression levels in BL and LBL feathers remained at the pre-injection level
throughout the 3 d sampling period (Figure 6C). TRP2 gene expression levels were higher
(P < 0.05) in SL compared to BL and LBL feathers at 3.5 h, 6 h and 3 d post-4-TBP
injection (Figure 6C).

Compared to pre-injection levels, the relative expression of anti-apoptotic BCL2 decreased
(P < 0.05) in SL chickens starting at 6 h post-4-TBP treatment and remained at low levels
throughout the sampling period. In BL and LBL controls the level of BCL2 expression was
elevated (P < 0.05) at 3 d post-4-TBP treatment (Figure 6D). Compared to BL and LBL
controls, BCL2 gene expression levels in SL feathers were higher at 1 h and lower (P < 0.05)
at 6 h and 3 d (Figure 6D).

The relative HSP70 expression in SL feathers was not affected by 4-TBP treatment during
the 3 day sampling period, whereas the expression of HSP70 in BL and LBL feathers
increased (P < 0.05) starting at 1 h, reached peak levels at 6 h and remained at high levels in
feather samples collected 3 d post-4-TBP injection (Figure 6E). HSP70 gene expression
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levels were lower (P < 0.05) in SL feathers at 1 h, 3.5 h, 6 h and 3 d (Figure 6E) compared
to levels observed in BL and LBL feathers.

The relative expression levels of TYR and the pro-apoptotic BAK1 protein in feather tips
from the different lines of chickens were not affected by 4-TBP treatment during the 3 d
observation period. However, the main effect mean for TYR expression over the course of
this study was higher in LBL compared to BL and SL feathers (Table 3).
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Table 1. Mononuclear cell infiltration into 4-TBP injected growing feathers from vitiligo
prone Smyth line (SL) and normally pigmented Brown line (BL), and Light Brown
Leghorn (LBL) chickens.
Mononuclear cell
infiltration
Area1 at 0h
Area1 at 1h
Area1 at 3.5h
Area1 at 6h
Area1 at 3d
Density1 at 0h
Density1 at 1h
Density1 at 3.5h
Density1at 6h
Density1 at 3d

SL (N=10)

BL (N=5)

LBL(N=5)

1.100 ± 0.076
2.400 ± 0.148
2.500 ± 0.148a
2.300 ± 0.218a
1.300 ± 0.120

1.000 ± 0.109
2.167 ± 0.214
2.000 ± 0.214b
2.000 ± 0.315a
1.000 ± 0.173

1.000 ± 0.109
2.000 ± 0.214
1.833 ± 0.214b
1.167 ± 0.315b
1.000 ± 0.173

0.400 ± 0.148
1.900 ± 0.182
1.500 ± 0.165
1.450 ± 0.138
0.700 ± 0.263

0.000 ± 0.214
1.833 ± 0.263
1.583 ± 0.239
1.167 ± 0.199
0.417 ± 0.379

0.167 ± 0.214
1.583 ± 0.263
1.667 ± 0.238
1.000 ± 0.199
0.250 ± 0.379

1

Mononuclear cell infiltration was evaluated based on area and density of infiltration.
Areas scores ranging from one to five were given to each feather after visual examination.
Score one to five were given according to the following infiltration: <20% (score
1); >20%,<40% (score 2); >40%, <60% (score 3); >60%, <80% (score 4); and >80%, <100%
(score 5). Density scores ranging from zero to three were given depending on the number
of leukocytes in 10 squares of a 10 mm by 10 mm ocular insert (1 square) viewed at 50 x
magnification under a microscope. The density scores were assigned according to the
following criteria: 0-20 cells (score 0), 20-100 cells (score 1), 100-150 cells (score 2),
and >150 cells (score 3) per square.
N = number of birds sampled at each time point
a,b

For each time point, means without a common letter are significantly different (P <
0.05).
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Table 2. Primer1 and probe1,2 sequences for target genes examined in the relative gene
expression analysis
Target Primer/probe Sequences (5' to 3')
Accession NO.
28S Forward
GGCGAAGCCAGAGGAAACT
X59733
Reverse
GACGACCGATTTGCACGTC
Probe
AGGACCGCTACGGACCTCCACCA
TYR Forward
ATAATGCCCTTCACATCTACATGAAT
NM_204160.1
Reverse
GCTCAAAAATGCTGTCAACAAATG
Probe
CTCAATGTCCCAAGTACAAGGCTCTGCG
TRP1 Forward
GGAACCATTTGTAACAGCACTGAAG
NM_205045.1
Reverse
CCATAGGCCGTGCAACATTT
Probe
CGGTCCCATCCGTAGAAATCCTGCTG
TRP2 Forward
CCTTTCCCGGCATGAGTTT
NM_204935.1
Reverse
AGCGCATTCCTGAAGCTGAA
Probe
CAGTCCTCCGTTTTTCCGCAATTCCA
MITF Forward
AAGAACTGGGCACCTTGATACC
NM_205029.1
Reverse
GATGTAGTCCACTGATGCTTTTAGAATAG
Probe
AAATCAAACGACCCGGATATGCGCTG
HSP70 Forward
GACTGCTCTCATCAAGCGTAACA
FJ217667.1
Reverse
TCATACACCTGGACGAGGACACT
Probe
CACCATTCCCACCAAACAAACACAGACC
BCL2 Forward
GCGTCAACCGGGAGATGT
NM_205339.1
Reverse
GGTTCAGGTACTCGGTCATCCA
Probe
CCGCTGGTGGACAACATTGCCA
BAK1 Forward
CCCTGCTGGGTTTCGGTTA
NM_001030920.1
Reverse
CGCAGGAAGCCCGTGAT
Probe
TGCATGGCCATCCACGTCTACCAG

1

Primer and probe oligos were synthesized by MWG Biotech, Hight Point, NC.

2

Probes had FAM (6-carboxyfluorescein) at 5’ end and TAMRA
(6-carboxytetramethylrhodamine) at 3’ end.
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Table 3. Relative expression1 of target genes not affected by 4-TBP during the course of
the 3 d study2
Gene

Smyth line

Brown line

Light Brown Leghorn

TYR

1.069 ± 0.062b

1.081 ± 0.061b

1.241 ± 0.061a

BAK1

1.084 ± 0.059

1.167 ± 0.059

1.170 ± 0.059

1

Relative expression of target genes was calculated by delta delta Ct method of data
obtained by qRT-PCR, where 28S served as endogenous control gene and a pool of cDNA
from feathers of age-matched parental line BL was use as the calibrator sample. Data were
analyzed by fit model of the JMP Pro 9 software and were shown as mean ± SEM.
2

Due to the absence of interactions between the effects of the line of chickens and time
points examined (0, 1, 3.5, 6 h and 3 d), the main effect means for each line of chicken are
shown.
a,b

For each target gene, means without a common letter are significantly different (P <
0.05).

119

A

B

D

E

C

F

G

Figure 1. Phenotypic expression of vitiligo in the Smyth line (SL) chicken and structural
features of growing feathers. A) pigmented SL chick at hatch; B) 14-week-old SL female
with vitiligo; C) 20-week-old vitiliginous SL rooster; D) 20-week-old SL rooster with
complete vitiligo; and E) 20-week-old Light Brown Leghorn (LBL) rooster without
vitiligo (normal pigmentation); F) growing feathers collected from SL chickens:
non-vitiligo (top), active vitiligo (middle) and complete vitiligo (bottom); G) Cross- and
longitudinal-sections of a growing chicken feather.
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Figure 2. Scoring of leukocyte infiltration into the pulp area injected with 4-TBP. A) The
ensheathed unit of living tissue in the newest growing feather. The ensheathed unit of
living tissue is approximately 8 - 10 mm from bottom to cap with a 3-4 mm diameter. Most
of the tissue consists of the inner pulp (sections were stained with Hematoxylin/Eosin stain
and viewed at 50x magnification using a bright-field microscope). Leukocyte infiltration
was scored based on area and density. Area scores ranging from one to five were given to
each feather after visual examination. Score one to five were given according to the extent
of infiltrated pulp area: <20% (score 1); >20%,<40% (score 2); >40%, <60% (score
3); >60%,<80% (score 4); and >80%,<100% (score 5). B) Density scores ranging from
zero to three were given according to the number of mononuclear cells in 10 squares of a
10 mm by 10 mm ocular insert (1 squares) when viewed on a bright-field microscope at
100 x magnification a) 0-20 cells (score 0), b) 20-100 cells (score 1), c) 100-150 cells
(score 2), and d) >150 cells (score 3) per square.
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Figure 3. Extent (Area score), density (Density score), and time course of mononuclear cell
infiltration into the pulp of 4-TBP injected feathers. Growing feathers of Smyth line (SL),
Brown line (BL), and Light Brown Leghorn (LBL) chickens were injected with 10 μL
4-TBP (0.15mg/mL; 1mM) into the feather pulp. Injected feather were collected at 0h, 1h,
3.5h, 6h and 3d after 4-TBP treatment and preserved in 10% buffered formalin for
conventional histology. Sections were stained with Hematoxylin/Eosin stain. Areas score
ranging from one to five were given to each feather after visual examination. Score one to
five were given according to the following infiltration: <20% (score 1); >20%,<40% (score
2); >40%, <60% (score 3); >60%; <80% (score 4); and >80%; <100% (score 5). Density
scores ranging from zero to three were given depending on the number of leukocytes in 10
squares of a 10 mm by 10 mm ocular insert (1 square) viewed at 50 x magnification under
a microscope. The density scores were assigned according to the following criteria: 0-20
cells (score 0), 20-100 cells (score 1), 100-150 cells (score 2), and >150 cells (score 3) per
square. Data were expressed as mean ± SEM. x,y For each line of chickens, means without a
common letter are different from the 0 h mean; a,b For each time point, means from each
line of chickens without a common letter are different (P < 0.05).
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Figure 4. Melanocyte morphology in pigmented growing feathers of 8-week-old Smyth
line (SL), Brown line (BL) and Light Brown Leghorn (LBL) chickens before (0 h) and at
various times after injection with 10 µL 4-TBP (0.15 mg/mL; 1mM). Injected feathers were
collected at 0h, 1h, 3.5h, 6h and 3d after 4-TBP treatment and preserved in 10% buffered
formalin for conventional histology. Sections were stained with Hematoxylin/Eosin stain
and viewed at a) 100x, b) 400x or c) 1000x magnification using a bright-field microscope.
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Figure 5. Total RNA quality assessment on the basis of 18S and 28S ribosomal RNA
(rRNA). Actual image of total RNA from isolated feather tissue after electrophoresis using
Experion StandardSen kit. Top: RNA ladder. Bottom: the intact total RNA with clearly
defined 18S and 28S rRNA bands.
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Figure 6. Time course of A) MITF, B) TRP1, C) TRP2, D) BCL2, and E) HSP70 gene
expression in Smyth line (SL), Brown line (BL) and Light Brown Leghorn (LBL) feathers
injected with 4-TBP. Growing feathers of SL chickens were injected with 10 µL 4-TBP
(0.15 mg/mL; 1mM) into the feather pulp. Injected feathers were collected at 0 h (before),
and 1 h, 3.5 h, 6 h and 3 d after 4-TBP treatment. The relative gene expression of MITF,
TRP1, TRP2, BCL2 and HSP70 was determined by quantitative real-time RT-PCR. The
relative change in expression was computed by the delta delta Ct method in which a pool
of cDNA from BL chickens was used as the calibrator samples and 28S was used as the
endogenous control in the qPCR. Data were expressed as mean ± SEM. x,y,z For each line of
chickens, means without a common letter are different from the 0 h mean. a,b,c For each
time point, means from each line of chicken without a common letter are different (P <
0.05).
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Discussion

Various environmental and genetic factors affect the development and progression of
vitiligo. In susceptible individuals, vitiligo development is initially triggered by
environmental factors including 4-TBP. Yang et al. (1999) reported that exposure to 4-TBP
of industry workers and consumers is widespread through phenolic detergents, synthetic
leather, glues, etc. 4-TBP is oxidized by tyrosinase to quinones (Thörneby-Andersson et al.,
2000), which cause futile redox cycling and cytotoxic levels of hydrogen peroxide
and glutathione disulfide (GSSG), thereby inducing and oxidative stress (O'Brien, 1992).
After 4-TBP exposure, genetic/epigenetic alterations may occur in affected melanocytes
resulting in vitiligo onset and progression in human.

In Chapter II of this dissertation, morphological abnormalities such as dendrite retraction
and mass aggregation were observed in SL MC cultures exposed to 4-TBP treatment,
which were less prominent in BL MC cultures. More importantly, MC-E cultures
established from SL chickens expressed a higher level of ROS accumulation in comparison
to those cultures derived from SL-G and BL embryos, emphasizing that these deficiencies
are inherent and not induced by differentiation in the feather environment of SL chickens.
In the current study, these morphological abnormalities were also observed in 4-TBP
injected melanocyte-containing feather tissue from SL chickens, including MC detachment
and dendrite retraction at 1 and 3.5 h post-injection. These MC alterations in response to
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4-TBP exposure in vivo were much less prominent in BL and LBL feather tissue (Figure 4).

In the previous study (Chapter II), the ROS generation response of melanocytes to 4-TBP
treatment in vitro were examined in SL and control chickens. Exposure of melanocytes to
4-TBP resulted in greatly heightened ROS generation in SL compared to control
melanocytes. This heightened sensitivity of SL melanocytes was associated with altered
MITF and TRP1 expression levels compared to controls 1 h after 4-TBP (the only
time-point examined), suggesting that the reduced ability to cope with oxidative stress in
SL chickens may be related to MITF regulation. In the current study, divergent responses in
vivo to 4-TBP injection of MC containing feathers were observed in SL compared to
controls regarding MITF, TRP1, TRP2, BCL2, and HSP70 expression.

MITF is considered as the master gene for melanocytic survival and a key transcription
factor for melanogenesis which can positively regulate genes of the melanogenic enzymes
TYR, TRP1, and TRP2. In the current study, it was revealed that the relative gene
expression of MITF in 4-TBP injected SL feathers dropped slightly at 1 and 3.5 h,
increased significantly at 6 h and dropped (P < 0.05) below pre-injection levels at 3 d after
4-TBP treatment. This increase from 3.5 h to 6 h was accompanied by elevated TRP1 and
TRP2 expression compared to pre-injection levels (Figure 6A-C). This is in accordance
with the regulation of TRP1 and TRP2 by MITF. In human vitiligo studies, 4-TBP
sensitivity of MC was directly related to TRP1 levels (Manga et al., 2006). Thus,
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up-regulation of TRP1 in SL chickens in response to 4-TBP may be similarly responsible
for the heightened 4-TBP sensitivity of SL MC (e.g. ROS production; Chapter II). The
increase in MITF, TRP1, and TRP2 observed between 3.5 and 6 h post-4-TBP injection is
contrary to the apparently protective response of decreased MITF and TRP1 expression in
BL and LBL feathers (Figure 6). The elevated levels of TRP2 in SL may however play a
protective role. In addition to the role in eumelanogenesis, where TRP2 catalyzes the
isomerization of DHICA from dopachrome, TRP2 may also plays a role in MC protection
during oxidative stress. Over-expression of TRP2 in the amelanotic WM35 melanoma cell
line was shown to reduce sensitivity to oxidative stress. However, these properties of TRP2
appeared to depend on a particular cell environment (Michard et al., 2008). Overall, the
divergent response to 4-TBP regarding MITF expression observed in feather samples from
vitiligo-susceptible SL compared to controls are in agreement with those reported for
human MC by Manga et al. (2006).

Yang et al. (2000) have reported that the destruction of MC by 4-TBP is through apoptosis.
Examination of BCL2 (anti-apoptotic protein) expression following 4-TBP exposure in
vivo in the present study revealed a gradual decrease of BCL2 in SL feathers, whereas
BCL2 expression in BL and LBL feathers was found to steadily increase (Figure 6D). This
divergent response in BCL2 expression in SL compared to controls, further supports a lack
of a protective response to 4-TBP exposure in vitiligo-susceptible individuals. While MITF
has been shown to control MC survival via BCL2 (McGill et al., 2002; Nishimura et al.,
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2005), the MITF expression pattern observed in controls (decrease) and SL (little change)
during the first 6 h following 4-TBP exposure does not suggest a regulatory role of MITF in
BCL2 expression in this situation.

In the current study, expression levels of the pro-apoptotic BCL2 homologs BAK1 did not
change following 4-TBP treatment in SL, BL and LBL chickens. It has been suggested
(Willis et al., 2007; Huang et al., 2012) that an increase in the BCL2:BAK1 ratio enables
greater engagement of anti-apoptotic BCL2 by the pro-apoptotic BH3 ligand, therefore
prompting survival of the cell. With reduction of BCL expression and no change in BAK1
expression in SL feathers following 4-TBP exposure, the proportions between these
proteins further support initiation of activities favoring apoptosis in SL MC.

ROS has the potential role to regulate the expression of HSP70. It appears that these
proteins in turn have the ability to protect cells and tissues from the deleterious effects of
inflammation. The mechanisms by which such protection occurs include prevention of
ROS-induced DNA strand damages, lipid peroxidation as well as protection of
mitochondrial function (Jacquier-Sarlin MR et al., 1994). Exposure of melanocytes to
4-TBP in vitro was found to result in HSP70 generation in cells from both the immortalized
human vitiligo MC cell line PIG3V and the normal human MC cell line PIG1. In 4-TBP
stimulated PIG3V MC, HSP70 was found to be released into the medium, a phenomenon
not observed in PIG1 MC. Moreover, high extracellular levels of HSP70 resulted in
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activation of dendritic cell (DC) effector functions focused on the stressed MCs. (Kroll et
al., 2005). Our study showed early and sustained elevation of HSP70 expression in BL and
LBL upon 4-TBP exposure, and no change in HSP70 expression levels in SL feathers
(Figure 6E). The complete lack of a HSP70 response to 4-TBP in SL-MC, which clearly
exhibit signs of cellular stress due to treatment, may reflect a serious alterations in their
ability to generate protective mechanisms during cellular stress.

Based on the in vivo effects of 4-TBP revealed in this study, it appears that reduced MITF
and TRP1 expression and increased HSP70 and BCL2 expression following MC exposure
to 4-TBP are protective responses that failed to be initiated in SL MC. A decrease in the
BCL2:BAK1 ratio in response to 4-TBP observed in SL MC may suggests that SL MC are
on a path towards apoptosis. Apoptotic MC may subsequently lead to immune recognition
of MC and initiation of a melanocyte-specific immune response. The mechanisms
underlying altered gene expression in SL MC upon exposure to 4-TBP need to be further
examined to gain insight into the etiology of the vitiligo. Specifically, functional studies
need to further examine the role the MITF, TRP1, and TRP2 in the response of MC to
oxidative stress.
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CHAPTER IV
ASSOCIATION OF HERPESVIRUS INFECTION AND IMMUNE ACTIVITIES
IN EVOLVING AUTOIMMUNE VITILIGO LESIONS IN SMYTH LINE OF
CHICKENS
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Abstract
The Smyth line (SL) of chicken is an animal model for human autoimmune vitiligo.
Multiple factors contribute to the death of melanocytes (MCs), including genetic
susceptibility to vitiligo (manifested in part as an inherent MC defect), as well as,
environmental factors that trigger autoimmune loss of SL MCs. Live turkey herpesvirus
(HVT, serotype 3 Marek’s disease virus; MDV) was identified as the most effective trigger
of SL vitiligo (SLV) expression in susceptible individuals. With the administration of live
HVT at hatch, onset of SLV can be observed between 6 and 20 wks of age and affects 80 95 % of SL chickens. However, little is known regarding the role and activities of HVT in
SLV development. Using SL and control chickens this study was conducted to determine
the ability of HVT to induce SLV expression at different ages; examine primary and recall
responses to HVT; and determine the association between HVT viral load and cytokine
production in the target tissue during SLV development and progression. The
SLV-triggering effect of HVT dropped substantially within the first 6 weeks of age and was
no longer observed at 10 weeks and onward. The primary and recall responses were similar
in SL chickens and BL- and LBL-controls in terms of leukocyte infiltration to the site of
HVT injection. Between 4.5 and 7 weeks post-HVT administration at hatch, the relative
HVT viral load (DNA) in SLV chickens was higher than in non-vitiliginous SL and BL
controls and reached peak-levels between 1 to 0.5 weeks before visible onset of SLV.
Moreover, there was a strong direct association between HVT levels, cytokine expression

139

and SLV onset. Specifically, the increased levels of HVT at 1 to 0.5 weeks before SLV
onset was accompanied by elevated cytokine expression of IL-8, IL-10, IFN-γ, and most
remarkably IL-21, supporting a Th1 phenotype of the autoimmune response. Low relative
expression of IL-4 did not suggest an important role of Th2 cells in SLV pathogenesis.
Taken together this study further supports a role of HVT in the expression of SLV in
susceptible individuals. HVT appears to exert its effect early in the life of a chick when
adaptive immunity is not fully developed. With the translocation of HVT to the feather and
the higher viral load in SL feathers just before SLV onset, the resulting immune activity
may cause cellular stress in the inherently fragile SL MC. Stress-associated MC alterations
may lead to immune recognition of MC and development of MC-specific autoimmune
disease.
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Introduction

Vitiligo is an acquired pigmentary disorder characterized by loss of epidermal melanocytes
(MCs) (Lerner, 1978) which results in patches of depigmentation, and in some patients,
complete depigmentation of the skin and its derivatives. This disorder is found in 0.1 - 2 %
of the world’s human population. Although the etiopathological mechanisms of this
disease are not well understood, it is generally believed that many factors contribute to
vitiligo development, including genetic susceptibility, environmental triggers, and immune
system involvement (Reza, 2011).

The Smyth line (SL) of chicken, exhibits many phenotypic and etiopathological
similarities with human vitiligo including the multifactorial nature of the disorder, high
incidence of vitiligo in the genetically susceptible group, and spontaneous onset, etc.
(Smyth, 1989; Erf, 2010). Together with the Brown line (BL) parental control (< 1 %
vitiligo) and Light Brown Leghorn (LBL) vitiligo resistant control the SL chicken model
has been established as a very important model for spontaneous autoimmune vitiligo (Erf,
2010; Wick et al., 2006). Live HVT is a reliable environmental trigger for vitiligo
expression in susceptible SL individuals. Onset of SL vitiligo (SLV) can be observed
between 6 to 20 weeks of age and affects 80 - 95 % of SL chickens receiving HVT at hatch.
Without HVT administration at hatch, the incidence of SLV drops to < 20 % and under
certain housing conditions to < 10%. HVT is an α-herpesvirus that belongs to the group of
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Marek’s disease viruses (MDV) (Calnek and Witter, 1991). MDVs include three serotypes:
MDV serotype-1 (MDV1) consists of oncogenic viruses and their attenuated derivatives;
MDV2 consists of related non-oncogenic viruses isolated from chickens; and HVT
(MDV3) consists of non-oncogenic viruses isolated from turkey (Erf et al., 2001). HVT is
used as a vaccine in chickens to protect them from MDV1 infection which causes T-cell
lymphomas and numerous mononuclear cell infiltration-associated lesions. Interestingly,
all MDV serotypes exhibit special tropism for feather tissue where MCs are located
(Holland et al., 1998) and all have similar effects on triggering vitiligo expression in
susceptible individuals (Erf, personal communication). Target MCs in chickens are located
in growing feathers which can be easily removed. Hence, HVT infection and the evolving
autoimmune lesion can be monitored prior to and throughout SLV development in the
same individual.

Similar to human autoimmune vitiligo, both humoral and cellular immunity play an
important role in SLV, with a more prominent role attributed to cellular immunity in MC
loss based on phenotypical analysis of leukocytes infiltrating the target tissue (Wang and
Erf, 2004; Shresta et al., 1997; Erf et al., 1995). Moreover, the presence of MC-specific
cell-mediated immunity was demonstrated in vivo based on the delayed wattle-swelling
response to injection of syngeneic MC lysates in chickens with SLV (Wang and Erf, 2003).
Immune functional gene expression activities during SLV development were recently
shown to be associated with IFN-γ, IL-21 and IL-10 co-expression in evolving
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autoimmune vitiligo lesions of SL chickens, indicating a Th1-polarized immune response
(Shi and Erf, 2012). Immune functional activities associated with the environmental trigger,
HVT, in SLV development have not been thoroughly examined. Preliminary data showed
elevated levels of CD4+ and CD8+ lymphocytes in skin and feather pulp from SL chickens
compared to BL chickens during a 1 to 6 week observation period post-HVT vaccination at
hatch. Likewise, HVT-vaccinated SL and BL chickens showed higher CD4+ and CD8+
cell infiltration than non-HVT- vaccinated SL and BL chickens in skin and feather pulp,
indicating a role of HVT infection in leukocyte infiltration in the feather pulp (Erf, personal
communication).

Using the SL vitiligo chicken model, the objectives of this study were to determine the
ability of HVT to induce SLV expression at different ages; examine the primary and recall
response activities to HVT in SL and control lines; and determine the association between
HVT viral load and immune function activities (i.e. cytokine production) in the evolving
autoimmune lesion. Specifically, the effect of HVT on SLV incidence was monitored by
giving HVT vaccination at hatch or when SL chickens were 2-, 4-, 6-, and 10-weeks of age.
Immune responses to HVT in SL, BL and LBL chickens were examined by monitoring
leukocytes infiltration in response to a primary and a secondary injection of HVT into
growing feathers over a 10 day period. To determine HVT viral load and cytokines gene
expression throughout SLV development, growing feather were collected twice a week
from the same individuals starting when the chicks were 2.5 weeks of age until SLV was
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fully established. Collected SL and control feather samples were then used for ex vivo
analysis. Using quantitative PCR (q-PCR), the presence of relative HVT viral load in
whole cross-section of feathers and in different areas of the cross-sections (MC area,
keratinocyte area, and pulp area) was monitored. Gene expression profiles in collected
feather tips were also established for cytokines of innate immunity (IL-1, IL-8, IL-10),
signature cytokines of T helper (Th)1 and Th2 (IFN-γ and IL-4, respectively) lymphocytes,
a pleiotropic cytokine IL-21, and for HVT-glycoprotein by qRT-PCR. Knowledge gained
from this study will broaden and deepen our understanding of pathogenic mechanisms
involved in the autoimmune loss of MCs in vitiligo development.
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Materials and Methods

Animals:

Three lines of MHC-matched (B101/101) chickens were used for these studies: 1) the
vitiligo-prone SL chickens which exhibits an 80 - 95% incidence of SLV by 20 weeks of
age under conventional rearing conditions, 2) the parental BL (< 1% incidence of vitiligo)
control chickens, and 3) the vitiligo-resistant LBL (no incidence of vitiligo) control line of
chickens (Erf, 2010). For all studies, each bird was tagged using a color-coded numbering
system to identify individual birds and birds from different lines. The chicks were raised in
floor pens on wood shavings litter. Food and water were available ad libitum. Chicks were
reared under standard diet, lighting and temperature protocols and their well-being was
checked daily. Vitiligo development was monitored by visual evaluation of pigmentation in
growing feathers and assigning a score ranging from 1 to 5 depending on the percentage of
growing feathers exhibiting pigmentation loss. [0 % (score 1), < 20 % (score 2), 20-60 %
(score 3), 60-99 % (score 4) and 99-100 % (score 5)] All procedures involving animals
were approved by the Institutional Animal Care and Use Committee (IACUC) Protocol
#08011.
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Study 1. SLV incidence post HVT injection at different age of chickens

Experimental design:

Forty newly hatched SL chicks from 35 families were assigned to Group 1 for HVT
administration on the day of hatch. For HVT administration, chicks were injected s.c. with
cell-free lyophilized live HVT vaccine (0.2 mL, est. 8000 pfu) following the
manufacturer’s instructions (MD-Vac CFL serotype 3, live, Fort Dodge Animal Health,
Fort Dodge, Iowa). Chicks in Group 1 where then raised under conventional farm
conditions at the Arkansas Experiment Station Poultry Farm in Fayetteville, AR.
One-hundred and twenty HVT-negative siblings of chicks from Group 1 were not HVT
vaccinated and reared in an isolation room equipped with a high efficiency particulate air
(HEPA) filter at the University of Arkansas, Division of Agriculture’s Poultry Health
Laboratory in Fayetteville, AR. Under these housing conditions, the incidence of SLV in
HVT-negative chickens has been repeatedly shown to be less than 10 % (Erf, personal
communication). Siblings from Group 1 (40/age group) were injected with HVT at 2-, 4-,
6-, or 10-weeks of age, and then moved to the Arkansas Experiment Station Poultry Farm
in Fayetteville, AR and reared under conventional farm conditions. SLV incidence was
monitored once per week until the chickens were 20 weeks of age.
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Study 2. Leukocyte infiltration in response to a primary and second administration
of HVT at hatch

Experimental design:

Two groups of SL, BL, and LBL chickens (N = 5 per line and group) were used for this
study. The first group (Group 1) was injected with live HVT vaccine (MD-Vac CFL
serotype 3, live, Fort Dodge Animal Health, Fort Dodge, Iowa) at hatch and reared on
Arkansas Experiment Station Poultry Farm in Fayetteville, AR; The second group (Group
2) was not injected with HVT at hatch (HVT-negative) and reared in an isolation room at
the University of Arkansas, Division of Agriculture’s, Poultry Health Laboratory in
Fayetteville, AR, as described above. When the birds were 18 weeks of age, 10 µL of HVT
(16000 pfu) were injected into 8 growing feathers on each breast track using insulin
syringes with the BD Ultra-FineTM needle (Capacity: 3/10cc,30 unit; Length: 8 mm; Gauge:
31 G; NDC/HRI# 08290-8438-01, Becton, Dickinson and Company). Growing feathers
were collected before (day 0) and at 1-, 2-, 3-, 5-, 7-, and 10 days after HVT injection and
placed into 10% buffered formalin for conventional histology. SL chickens in Group 1 had
complete vitiligo with 100% of amelanotic feathers, whereas all of the SL chickens in
Group 2 exhibited no sign of SLV at the time of treatment.
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Assessment of leukocyte infiltration into HVT injected feathers

Formalin fixed, processed and paraffin-embedded feather samples were cut into
longitudinal sections (6 μm thick) and stained with Hematoxylin/Eosin (University of
Arkansas, Division of Agriculture, Histology Laboratory). Sections were examined for
leukocyte presence and type of leukocyte (granulocyte or mononuclear cells using a bright
field microscope (400 x magnification). The intensity of leukocyte infiltration into the
ensheathed unit of living feather tissue in response to HVT was assessed based on the
proportion of infiltrated to total tissue area (% area) and density of infiltration. Area scores
ranging from one to five were given to each feather after visually examination under a
bright field microscope (50 x magnification). Area scores one to five were given according
to the following infiltration levels: <20 % (score 1); >20 %,<40 % (score 2); >40 %,<60 %
(score 3); >60 %,<80 % (score 4); and >80 %,<100 % (score 5). Density scores ranging
from zero to three were given depending on the number of leukocytes in 10 squares of a 10
mm by 10 mm ocular insert (1 square) viewed at 50 x magnification under a microscope.
The density scores were assigned according to the following criteria: 0-20 cells/square
(score 0), 20-100 cells/square (score 1), 100-150 cells/square (score 2), and >150
cells/square (score 3).
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Study 3. Examination of relative HVT-glycoprotein (gp) expression in spleen and
growing feathers

Experimental design:

Feather tips and spleen from a previous study (Bateman, 2008) were used to examine the
expression of HVT-gp in growing feathers and spleen from SL, BL and LBL chicks that
were HVT-vaccinated at hatch. Spleen and growing feathers were collected from 5 to 10
chicks/line at day 5, 8, 12, 15, 21, 28, 35 and 42 post-hatch. Portions of each tissue sample
were placed in RNA stabilizing buffer (RNAlater, Quiagen, Valincia, CA) for RNA
isolation. These tissues were then placed in the -80°C ultra low freezer for storage until use
for RNA extraction, cDNA prearation and qPCR (see Study 4).

Study 4. Assessment of the relative HVT viral load and cytokines profiles in growing
feathers throughout vitiligo development

Experimental design:

To study the relative HVT viral load and expression of immune-response related cytokines
throughout SLV development and progression from each individual chicken, 18 SL and 6
BL chickens were randomly selected from different families on the day of hatch after HVT
vaccination. Two feathers were snap frozen in liquid nitrogen for RNA analysis and four
feathers were collected from SL and BL chickens every half week starting when the chicks
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were 2.5 weeks of age until stable SLV development in SL chickens. At each collection
time, and once per week thereafter until all SL chicks were 20 weeks of age, SLV
development was monitored and the extent of depigmentation scored as described above.
[20 weeks of age is the natural end-point of SLV development as feather growth, and hence
pigmentation, is complete in adult chickens]. Two of the 4 feathers were snap frozen in
liquid nitrogen for RNA analysis, the other 2 were placed in embedding medium (Optimal
Cutting Temperature, O.C.T, VWR International, Bridgeport, NJ), and snap frozen in
liquid nitrogen. All samples were stored at -80°C until use. Based on SLV development in
SL chickens by 20 weeks of age, SL samples were placed into two SL groups: SLV and SL
no vitiligo (SLnoV).

RNA extraction, quantification, and cDNA synthesis:

Total RNA was isolated from spleen (Study 3) and the 3 mm newest growth of the snap
frozen feather tips which contains the epidermal tissue where MCs are located. Tissues
were homogenized by Tissue Tearor (BioSpec Products, Bartlesville, OK, Model:
985370-395) RNA was isolated using the RNeasy® Mini Kit (Qiagen, Valencia, CA) and
following the protocol for “Purification of Total RNA from Animal Tissues” with
modifications.) Following RNA isolation from homogenates with on-column DNA
digestion (Qiagen), RNA was eluted in 30 µL RNase-, DNase-free water and stored at
-80°C until use. RNA quality and quantity were determined by ExperionTM RNA
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StardardSens Reagents and Supplies (Bio-Rad Laboratories, Hercules, CA) following
manufacturer’s instructions. RNA (175 ng) was reverse transcribed into cDNA by High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) in a 10
μL reaction volume according to manufacturer’s instruction. A Biometra® personal cycler
(Biomedizinische Analytick GmbH, Germany) was programmed as follows: 25ºC for 10
min, 37ºC for 2 h, 85ºC for 5 min and 4ºC holding temperature. Then cDNA was stored at
-80ºC until further analysis.

Feather Section Collection Using Laser Capture Microdissection (LCM):

Frosted glass slides were first wiped with 70% alcohol (70 volume absolute alcohol and 30
volume RNase-, DNase- free water; MP Biomedials, LLC, Solon, Ohio). After being
air-dried at room temperature, the slide was wiped with RNase AWAY® (Molecular
Bioproducts, Inc., San Diego, CA) in a hood to remove RNase and DNA contamination.
Frozen O.C.T blocks containing feather tips were trimmed and placed onto a tissue holder
in the proper cutting orientation to obtain cross-sections starting at the bottom of the
feather tip (newest growth). Frozen sections were cut at -20ºC (12 μm thick) in the cryostat
and were closely checked for melanin deposition under a bright-field microscope. Actual
section collection onto pre-treated and pre-cooled slides started shortly after the first
sections with a clearly pigmented barb ridge was identified. Four sections were placed onto
each slide. Slides were then exposed to the following dehydration procedure: 30 s in 75%
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alcohol, 30 s in 95% alcohol, l min in each of two 100% alcohol baths and 5 min in each of
two xylene baths while it was acceptable that slides were kept in the last xylene bath for up
to 2 h.

LCM was carried out with a P.A.L.M. microlaser systems (P.A.L.M. Microlaser
Technologies AG, Germany) including PALM® Robo Software microlaser systems
version 3.0-0804 (EN) (P. A. L. M. Microlaser Technologies AG, Germany) and PALM®
Micro Beam version 1104 Z (P. A. L. M. Microlaser Technologies AG, Germany). Sections
were viewed under 200 x magnification. The barb ridge area, where MC are located at the
interface of the pulp and the barb ridge (MC-area) and the area where keratinocytes are
located at the interphase of the outer sheath and the barb ridge (keratinocyte-area), and the
pulp area were premarked using the Freehand Tool. MC-, keratinocyte- and pulp-area were
cut and catapulted into Adhesive Cap (Carl Zeiss Microimaging GmbH, Germany) using
the function of AutoLPC. Parameters for laser functions were as follows: UV energy 72;
UV focuses 69; LPC energy 91; Distance of autoLPC shots 12 um; stage movement
100steps/sec. Collecting tubes were kept in -80 ºC before next step of DNA extraction.

DNA extraction and quantiation from LCM samples:

The Pico PureTM DNA Extraction Kit (Applied Biosystems, Foster City, CA) was used to
extract DNA from LCM collected MC-, keratinocyte- and pulp- area cells. Samples were
incubated with 30 µL of PicoPure DNA Extraction Buffer containing Proteinase K at 65°C
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for 16 h, followed by 95°C for 10 min to inactivate Proteinase K. Then, sample tubes were
transferred on ice for use in qPCR, either directly after collection or after storage at -80°C.

Taqman® quantitative PCR (qPCR):

qPCR was performed on the cDNA samples (primers and probes are shown in Table 1) in
25 μL reaction volume on a ABI PRISM 7300 sequence detection system (Applied
Biosystems, Foster City, CA) using the Universal PCR Master Mix (Applied Biosystems,
Foster City, CA) and following manufacturer’s instruction. In each plate, a calibrator
sample (a pool of cDNA from age-matched BL birds), a non-template control, and sample
cDNA were included. 28S ribosomal RNA was the endogenous control gene. Cycling
profiles used were 94ºC for 15 min, and 50 cycles of denaturation at 94ºC for 60 s, and
annealing/extension at 60ºC for 60 s. The relative gene expression was determined by the
delta delta Ct (∆∆Ct) method (Wong and Medrano, 2005). DNA quality and concentration
were determined by NanoDrop 1000 Spectrophotometer from Thermo Scientific.
Statistical Analysis
Statistical analysis was carried out using JMP Pro 9 (JMP Software Inc., Cary, NC).
Two-way ANOVA was used to examine the effects of line of chicken, time, and line by
time interaction on the relative expression of each target gene, HVT viral load, area and
density of leukocyte infiltration. In the presence of significant main effects for line and/or
time, and the absence of line by time interactions, Fisher’s LSD multiple means
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comparison was used to determine differences among group means. P values ≤ 0.05 were
considered significant. Data were reported as means ± SEM.
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Results

SLV incidence following HVT-administration at different ages post-hatch

Ninety-two % of SL chicks injected with live HVT at hatch (one day old) and raised under
conventional farm conditions developed SLV, whereas HVT-negative (not injected with
HVT at hatch) siblings raised in floor pens in an isolation room equipped with a HEPA
filter had an SLV incidence of <10%. The SLV incidence of SL siblings injected with live
HVT at 2-, 4-, 6-, and 10- weeks post-hatch were 72.5%, 52.5%, 35%, and 0% respectively
at 20 weeks of age (Figure 3).

Leukocyte infiltration into the pulp of HVT injected growing feathers in
HVT-vaccinated and -unvaccinated 18-week-old chickens

Leukocyte infiltration in response to a primary or second exposure of HVT was found to be
mononuclear in nature. For the primary response to HVT injection, compared to
pre-injection levels, the area score of mononuclear infiltration (lymphocytes and
macrophages) in SL feathers increased (P < 0.05) at 1 d, reached peak levels (P < 0.05) at 5
d, and dropped (P < 0.05) to 1 d levels at 7 d, and remained at this level at 10 d. By
comparison, in BL and LBL feathers, area score increased (P < 0.05) at 1 d and remained at
this high level throughout the 10 d sampling period (Figure 4A). Compared to BL and LBL
controls, area scores for the primary response were higher in SL feathers at 5 d (Figure 4A).
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In the primary response, density score of SL, BL, and LBL feathers increased (P < 0.05) at
1 d compared to pre-injection levels and remained at this high level throughout the 10 d
sampling period (Figure 4B). There was no difference in density score among lines (SL,
BL, and LBL; Figure 4B).

For the secondary (recall) response to HVT injection, compared to pre-injection levels, the
mononuclear cell area score and density score in SL, BL and LBL feathers increased (P <
0.05) at 1 d stayed at this high level on 2 d, dropped (P < 0.05) at 3 d, and remained at this
still elevated level throughout the 10 d sampling period. With the exception of higher (P <
0.05) area and density scores for BL on day 10, there were no line differences in leukocyte
infiltration during the recall response to HVT 18-weeks post-primary HVT administration
at hatch (Figure 4C and 4D).

The relative HVT viral load in cells from the whole- and MC-, keratinocyte- and
pulp-area of feather sections from SLV, SLnoV and BL chickens post-HVT injection
at hatch

Due to the dramatic change of HVT viral load at different observation time, data were
converted to base 10 logarithmic values.

There were no differences in the relative HVT viral load in SL (SLV and SLnoV) and BL
feathers before 4 weeks post-HVT vaccination at hatch. Specifically, compared to viral
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load levels at 2.5 week, the relative HVT viral load in SL and BL decreased (more than
1000 fold change; P < 0.01) at 3 wks post-HVT vaccination, increased (P < 0.01) at 3.5 wks,
and reached peak-levels at 4 wks (Figure 5). The relative HVT viral load in SLV chickens
remained at a constant high level after 4 wks until a drop (P < 0.01) at 7 wks, and remained
at the lower level thereafter (Figure 5); whereas, in SLnoV and BL feathers, HVT levels
decreased (P < 0.05) from 4 wks to 4.5 wks (Figure 5), and remained at lower level until a
further drop at week 7.5 (Figure 5). Generally, compared to BL and SLnoV feather viral
load, the levels in the SLV chickens were higher from week 4.5 to week 7 (Figure 5).

With each vitiliginous chicken developing SLV at different weeks of age, data for each
SLV bird were aligned with respect to time of visible SLV onset for time course
comparisons. As data from SLV and BL feathers collected at the ages as SLV data
(corresponding to -4.5 wks and +1.5 wks with respect to SLV onset in SL) did not fluctuate
significantly (P > 0.1), the mean ± SEM across age was used for comparison to SLV data
(Figure 6 and 9). With respect to vitiligo onset in SLV feathers, the relative HVT viral load
in SLV increased (P < 0.05) starting at 4 wks, reached peak levels at -1 and -0.5 wks, then
decreased (P < 0.05) starting at onset (0 wks) and reached the lowest level at 1.5 wks. HVT
levels in SLV feathers were higher (P < 0.05) than the mean HVT levels in BL and SLnoV
feathers (Figure 6). The expression of HVT-gp could only be detected in the spleen and not
in feathers from all three lines of chicken (Figure 8). The pattern of expression of HVT-gp
in the spleen tended to be biphasic in SL and BL spleens (Fig. 8B). Specifically in SL
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spleens, relative HVT-gp expression levels peaked at 8 d, drop to low levels at 15 d then
increased again at 21 d reaching higher levels compared to controls (BL and LBL; P < 0.05)
at 28 to 42 days of age. Due to large variation in HVT-gp expression there was no statistical
difference over time in HTV-gp expression levels in BL and LBL spleens. Correlation
analysis of HVT load in different areas of feather sections with that from entire feather
sections revealed a stronger relationship between relative amount of HVT in the MC-area
and whole feather cross-sections for SLV (R2 = 0.69) and SLnoV (R2 = 0.68) chickens than
for BL (R2 = 0.43) chickens (Figure 7). The viral load in most of the samples collected from
the keratinocyte-area and the pulp-area could not be determined due to undetected levels of
HVT DNA in the qPCR assay (data not shown).

Profiles of cytokine and tyrosinase (TYR) expression at different weeks post-HVT
vaccination at hatch and throughout SLV development

Owing to limited availability of chicken-specific antibodies, cytokine and TYR expression
was examined at the transcriptional level using quantitative reverse-transcription real-time
PCR (qRT-PCR). The relative expression was calculated by ΔΔCt method using a cDNA
pool made from RNA of 16 growing feather of BL chickens from each time point as the
calibrator and chicken 28S as the endogenous control gene. Data were expressed as fold
change at different weeks post HVT vaccination. Starting at 6 weeks of age, IL-8, IL-10,
IL-21, and IFN-gamma showed elevated expression in feathers from SLV chickens and
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reached peak levels near 8 weeks of age, whereas, in SLnoV and BL feathers expression of
these cytokines did not change significantly during the observation period (Appendix 1).
The expression of IL-1 in SLnoV and SLV was slightly increased at 6 weeks, and then
remained elevated level until 9 weeks of age, whereas, the expression of IL-1 in BL was
similar with the exception of increased expression at 8 weeks (Appendix 1). The
expression level of IL-4 was similar over the entire observation period in BL, SLnoV, and
SLV feathers, except a high value at 8 weeks in BL chickens. TYR expression in feathers
from all birds fluctuated with age but did not differ significantly between lines of chickens
(Appendix 1).

As each vitiliginous chicken developed SLV at different weeks of age, SLV data were
expressed with respect to onset (0 time) to demonstrate the general trend of cytokine and
TYR expression in SLV development and progression. Mean data, pooled across time for
BL and SLnoV samples were used for comparison with SLV data (see HVT section above).
In the feather tips collected from SLV chickens, IL-1, IL-4 and TYR were similar to those
of BL and SLnoV samples at all time-points, except a peak increase of IL-1 at 1 wk after
the onset of vitiligo and extremely low levels of TYR in white SLV feathers (complete
SLV). Relative expression of IL-8, IL-10, IL-21 and IFN-γ in SLV samples exhibited
greater than 3 fold higher levels than BL and SLnoV samples (Figure 9). During or near the
onset of SLV, parallel increases in the relative expression of IL-8, IL-10, IL-21 and IFN-γ
could be observed in the SLV feathers, with higher expression levels than those in
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age-matched BL and SLnoV feathers. These four cytokines simultaneously reaching peak
levels and remaining elevated until 3 wks post SLV onset (Figure 9). The relative
expression of chemokine IL-8 and cytokines IL-10, IL-21 and IFN-γ emerged as the
signature cytokine profile during the early stage and active progression of SLV in feathers
from all vitiliginous chickens. Comparison of SLnoV and BL main effects means
(averaged over time) revealed higher levels of IL-21 and IFN-γ in feathers of SLnoV
chickens (Table 2).
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Table 1. Primer1 and probe1,2 sequences for target genes examined in the relative
expression analysis
Target
28S

IL-1

IL-4

IL-8

IL-10

IL-21

IFN-γ

TYR

1

Primer/Probe Sequences (5' to 3')
Forward
GGCGAAGCCAGAGGAAACT
Reverse
GACGACCGATTTGCACGTC
Probe
AGGACCGCTACGGACCTCCACCA
Forward
GCTCTACATGTCGTGTGTGATGAG
Reverse
TGTCGATGTCCCGCATGA
Probe
CCACACTGCAGCTGGAGGAAGCC
Forward
AACATGCGTCAGCTCCTGAAT
Reverse
TCTGCTAGGAACTTCTCCATTGAA
Probe
AGCAGCACCTCCCTCAAGGCACC
Forward
GCCCTCCTCCTGGTTTCA
Reverse
TGGCACCGCAGCTCATT
Probe
TCTTTACCAGCGTCCTACCTTGCGACA
Forward
CATGCTGCTGGGCCTGAA
Reverse
CGTCTCCTTGATCTGCTTGATG
Probe
CGACGATGCGGCGCTGTCA
Forward
GTGGTGAAAGATAAGGATGTCGAA
Reverse
TGCCATTCTGGAAGCAGGTT
Probe
TGCTGCATACACCAGAAAACCCTGGG
Forward
GTGAAGAAGGTGAAAGATATCATGGA
Reverse
GCTTTGCGCTGGATTCTCA
Probe
TGGCCAAGCTCCCGATGAACGA
Forward
ATAATGCCCTTCACATCTACATGAAT
Reverse
GCTCAAAAATGCTGTCAACAAATG
Probe
CTCAATGTCCCAAGTACAAGGCTCTGCG

Accession NO.
X59733

AJ245728

AJ621735

AJ009800

AJ621614

NM_001024835.1

Y07922

NM_204160.1

Primer and probe oligos were synthesized by MWG Biotech, Hight Point, NC.

2

Probes had FAM (6-carboxyfluorescein) at 5’ end and TAMRA
(6-carboxytetramethylrhodamine) at 3’ end.
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Table 2. The line of chicken main effects on the relative expression1 of target genes from
BL and SL chickens without vitiligo.
Gene

BL

IL-1
IL-4
IL-8
IL-10
IL-21
IFN-γ
TYR

1.40 ±0.26
1.62 ± 0.43
1.00 ± 0.16
0.83 ± 0.49a
0.11 ± 0.09a
0.58 ± 0.11a
2.85 ± 0.29

SL without
vitiligo
1.73 ± 0.20
1.15 ± 0.34
1.13 ± 0.12
2.40 ± 0.39b
0.62 ± 0.07b
1.38 ± 0.09b
2.50 ± 0.23

Main effect
(P-value)
0.31
0.39
0.49
0.01
<0.001
<0.001
0.35

1

Relative expression of targets was calculated by the delta delta Ct method of data obtained
by real-time PCR, where S28 served as endogeneous control gene and a pool of cDNA
from 16 growing feather of BL chickens from each time point was used as the calibrator
sample. Data were analyzed by Fit Y by X of the JMP 9.0 software and were shown as
mean ± SEM.

a,b

For each target gene, means without a common letter are significantly different (P <
0.05).
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Table 3. The line of chicken main effect on relative HVT viral load1 in whole feather
sections and melanocyte-areas from SL and BL chickens.
HVT Load Location
Whole Feather Sections
MC Areas

BL

SL

0.21 ± 0.14
-1.60 ± 0.25

0.43 ± 0.09
-1.36 ± 0.14

1

Main Effect
(P-value)
0.18
0.41

Relative amount of HVT DNA was calculated using the delta delta Ct method of data
obtained by Real-time PCR, where S28 served as endogeneous control gene and a pool of
cDNA from 11 whole feather sections of BL chickens from each time point was used as the
calibrator sample. Data were analyzed by Fit Y by X of the JMP 9.0 software and were
shown as mean ± SEM.
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Figure 1. SL chickens and morphology of their 2- to 3-week-old growing feathers. a) SL
chicks hatch with normal pigmentation. b) SL chicken with vitiligo; loss of feather
pigmentation due to loss of melanocytes (MCs) in the feather. The ensheathed unit of
living tissue of growing feathers is approximately 8-10 mm in length and 1-3 mm in width
(depending on the age of the chicken). c) bottom newest growth of feather, d) oldest growth
of feather with epidermal cap. Most of the tissue consists of the inner pulp (dermis).
Sections were stained with Hematoxylin/Eosin stain and viewed at 50x magnification
using a bright-field microscope. c) also shows 1) the portion of the feather tip where12 µm
cross sections were taken for the LCM study and 2) where the 100 µm cross sections for
HVT viral load determination (whole feather sections) were cut.
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a

b

c

d

Figure 2. Morphology of melanocytes (MCs) in feather cross-section from SL chickens.
The unstained cross-sections of snap frozen feathers showing MC morphology in a) the
normally pigmented and b) active vitiligo SL barb ridge area of a feather tip cross section.
c) and d) shows the dehydrated feather cross-sections before and after removal of MC-area
in the barb ridge where the MC cell bodies are located. Sections were viewed at 200x
magnification under a bright field laser capture microscope.
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Figure 3. SLV incidence following HVT-administration at different ages post-hatch. The
sibling of SL chicks (N = 40/group) were injected with live HVT at hatch or at 2-, 4-, 6-,
and 10 weeks post-hatch. Non-vaccinated chicks were raised in isolation room (BSL 2)
equipped with a high efficiency particulate air filter until HVT administration. Following
HVT vaccination SL chicks were then moved to conventional farm conditions. SLV
incidence was monitored until chickens were 20 weeks of age.
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Figure 4. Mononuclear cell infiltration in the pulp of growing feathers injected with HVT.
Growing feathers of Smyth line (SL), Brown line (BL), and Light Brown Leghorn (LBL)
chickens were injected with 10 µL HVT (16000 pfu) into the feather pulp. Injected feather
were collected at 1-, 2-, 3-, 5-, 7-, and 10-days post-HVT vaccination and preserved in 10%
buffered formalin for conventional histology. Sections were stained with
Hematoxylin/Eosin stain. The area scores ranging from one to five was given to each
feather after visually examination according to the following infiltration: <20% (score
1); >20%,<40% (score 2); >40%,<60% (score 3); >60%,<80% (score 4); and >80%,<100%
(score 5). Density scores ranging from zero to three were given depending on the number
of leukocytes in 10 squares of a 100 square (10 mm by 10 mm) ocular insert viewed at 50 x
magnification under a microscope. The density scores were assigned according to the
following criteria: 0-20 cells (score 0), 20-100 cells (score 1), 100-150 cells (score 2),
and >150 cells (score 3). Data were expressed as mean ± SEM.
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Figure 5. The effect of time (weeks post-HVT vaccination) on the relative amount (fold
change) of HVT DNA in whole feather sections from HVT vaccinated SLV, SLnoV, and
BL chicks. One-day-old chicks from the vitiligo-prone SL and parental BL chickens were
vaccinated with HVT and feather samples were collected at 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5,
7, and 7.5 weeks post-vaccination. DNA from three whole 100 µm cross-sections of
feather sample was extracted using Pico PureTM DNA Extraction Kit (Applied Biosystems,
Foster City, CA). The relative amount of HVT DNA present in each sample was then
quantified by real-time PCR using an ABI PRISM 7700 sequence detection system
(Applied Biosystems, Forest City, CA). For each sample, the relative amount of HVT DNA
was calculated using the ΔΔCt method described by Applied Biosystems (Forest City, CA)
and data expressed as the fold difference with respect to a calibrator sample from 11 whole
feather cross-sections collected from BL chickens from each time point. For each time
point, data shown are mean ± SEM each BL (N = 4), SLnoV (N = 4), SLV (N = 6) chickens
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Figure 6.Time course with respect to vitiligo onset of the relative amount (fold change) of
HVT DNA in the whole feather sections from HVT vaccinated SLV, SLnoV, and BL
chicks. One-day-old chicks from the vitiligo-prone SL and parental BL chickens were
vaccinated with HVT and feather samples were collected at 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5,
7, and 7.5 weeks post-vaccination. DNA from three whole 100 µm cross-sections of
feather sample was extracted using Pico PureTM DNA Extraction Kit (Applied Biosystems,
Foster City, CA). The relative amount of HVT DNA present in each sample was then
quantified by real-time PCR using an ABI PRISM 7700 sequence detection system
(Applied Biosystems, Forest City, CA). For each sample, the relative amount of HVT DNA
was calculated using the ΔΔCt method described by Applied Biosystems (Forest City, CA)
and data expressed as the fold difference with respect to calibrator sample from 11 whole
feather sections of BL chickens from each time point. The X-axis represents the time
(weeks) of feather cross-section collection with respect to vitiligo onset (0), BL and SLnoV
represent the pooled data from feather cross-sections collected from age-matched BL and
SLnoV throughout the course of the study. Data are mean ± SEM of relative amount of
HVT in feathers from 6 SLV, 4 SLnoV and 4 BL, chickens.
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Figure 7. Relationship between relative amount of HVT in the melanocyte (MC) area and
in the whole cross section of feather samples. One-day-old SL and BL chicks (N=10 and 4
per time point, respectively) were vaccinated with HVT at hatch and feather samples were
collected at 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, and 7.5 weeks post-vaccination. DNA from
three whole 100 µm cross-sections of each feather sample and from MCs collected by
LCM (three 12 µm cross sections) was extracted using Pico PureTM DNA Extraction Kit
(Applied Biosystems, Foster City, CA). The relative amount of HVT DNA present in each
sample was then quantified by real-time PCR using an ABI PRISM 7700 sequence
detection system (Applied Biosystems, Forest City, CA). For each sample, the relative
amount of HVT DNA was calculated using the ΔΔCt method described by Applied
Biosystems (Forest City, CA) and data expressed as the fold difference with respect to a
calibrator sample from 11 whole feather cross-sections of BL chickens from each time
point. The data were transformed to Log 10 .
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Figure 8. Time course of HVT glycoprotein (HVT-gp) gene expression in A) feather and B)
spleen collected from SL, BL, and LBL chickens post-HVT vaccination at hatch.
One-day-old chicks from the vitiligo-prone SL, parental BL and LBL chickens (N=40)
were vaccinated with HVT at hatch. Feather and spleen samples were collected from 5
euthanized birds from each line at 5, 8, 12, 15, 21, 28, 35, and 42 days post-vaccination.
Relative expression was calculated by the ΔΔC t method, using a cDNA pool made from 8
growing feather of BL chickens from each time point as the calibrator and chicken 28S as
the endogenous control gene. The X-axis represents the time (days) of feather tip collection
post HVT vaccination. Data were reported as means ± SEM.
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Figure 9. Time course of relative cytokine and tyrosinase gene expression with respect to
SLV onset in growing feathers from HVT-vaccinated SLV chicks. A) IL-1, B) IL-4, C)
IL-8, D) IL-10, E) IL-21, F) IFN-γ and G) tyrosinase (TYR). Relative expression was
calculated by the ΔΔC t method from 10 SLV birds, using a cDNA pool made from 16
growing feather of BL chickens from each time point as the calibrator and chicken 28S as
the endogenous control gene. The X-axis represents the time (weeks) of feather tip
collection post HVT vaccination. Weeks -7 to -0.5 represent early vitiligo and weeks 0-4
correspond to active vitiligo. BL and SLnoV data are the mean expression level overtime in
feathers from BL and SL without vitiligo. *shows TYR expression in completely
amelanotic feathers.
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Discussion

Vitiligo in SL chickens is an acquired idiopathic dermatological disorder characterized by
postnatal loss of pigment-producing cells (MCs) in the feather and the choroid which
results in white feathers (Smyth, 1989). Genetic predisposition (inherent MC defect),
immune system components, as well as environmental factors are known to play a role in
the pigmentation loss (Smyth, 1989; Erf, 2006). Previous observation showed that SL
chickens without HVT administration at hatch had a substantially lower incidence of
vitiligo (< 20%) compared to 80 - 95% of SL chickens vaccinated with live HVT at hatch
(Erf et al., 2001). Recent development in housing conditions, reliably reduced the
incidence of SLV in unvaccinated SL chickens to < 10% (no HVT administration and
rearing of chicks in a HEPA filtered room; Erf personal communication). The large
difference in SLV incidence in HVT-positive and HVT-negative SL chickens provides
unique opportunity for study of HVT and other environmental triggers of SLV expression
in susceptible SL chickens.

Live HVT is not the only MDV serotype that can trigger SLV expression. Live MDV1
(oncogenic) and live vaccine MDV2 (non-oncogenic chicken MDV), like MDV3 (HVT),
were found to trigger SLV expression to a similar extent. This finding, together with
reports that inactivated HVT and other live vaccine viruses (NDV, IBV), an mycoplasma
infection, did not influences SLV expression (Erf et al., 2001; Erf, 2010), strongly suggests
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that the ability of MDV viruses to influence SLV is unique to these α-herpesviruses. In this
study, the strong association of HVT administration at hatch and the incidence of SLV was
confirmed. However, with later time of HVT administration, SLV incidence decreased
substantially by 6 weeks and SLV was no longer observed when HVT was administered at
and after 10 weeks of age (Figure 3). This indirect relationship between age at HVT
administration and SLV incidence needs further investigation, but may be related to a more
fully developed, better regulated adaptive immune system and/or more robust MCs in older
birds. A feature of MDV viruses, such as HVT, that may be related to SLV expression is
the fact that these viruses translocate to the feather follicle where they replicate in the
feather follicle epithelium. It has been our hypothesis (Erf , 2010) that the presence of the
HVT-infection and the resulting immune response activity at this location, causes cellular
stress to the inherently fragile MC of SL chickens. Stressed or apoptotic MC then draw the
attention of the adaptive immune system to MC and the MC specific immune response
develops (Erf, 2010). The observation in the current study further supports this hypothesis.

To examine whether SL chickens respond differently to a first and/or repeat HVT infection,
a study was carried out to observe the mononuclear cell infiltration in feathers directly
injected with HVT into the feather pulp area. Typically both SL and control chickens
showed mononuclear cell infiltration in the feather pulp post HVT injection (Figure 4). The
general mononuclear cell infiltration pattern was similar for the primary as well as the
recall response in feathers from SL, BL and LBL chickens. While SL exhibited more
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extensive infiltration at several time-points post-HVT injection, the differences were not so
large as to suggest that heightened reactivity of SL to HVT is a factor in triggering SLV.
However, this study was conducted when chicks were 18 weeks of age and it is possible
that immune activity, both innate and adaptive, to HVT at a very young age may be
substantially different in vitiligo-prone SL and control chickens.

It may also be possible that the extent of HVT infection is different in SL compared to BL
and LBL controls which could influence the local MC environment and cause MC cellular
stress. Interestingly, previous study showed no differences in relative HVT-viral load in
the feathers from, SL, BL, and LBL chickens over a 42 day period post HVT vaccination,
whereas SL had higher viral load in spleen than BL chickens. In both, feathers and spleen,
HVT viral load levels exhibited a biphasic pattern in all three lines of chickens, with peak
levels early during infection, a drop at 21 days, and another peak at 28-35 days post HVT
vaccination (Bateman, 2008). The current study was conducted to further examine the
association between HVT levels and expression of SLV. Specifically, the relative viral
load of HVT in feathers was compared between HVT-vaccinated chicks from SLV, SLnoV
(did not develop SLV) and BL chickens using a time course approach to examine feather
tissue in the same individuals. It shows the dramatic decrease of HVT viral load in both SL
and BL chickens from 2.5 to 3 weeks which is consistent with previous data (Bateman,
2008). The elevated HVT viral load in SLV feathers as compared with SLnoV and BL
feathers starting from 4.5 weeks up to 7 weeks (the time when most SLV developed)
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(Figure 6) suggests a link between HVT load in SLV birds and the expression of SLV.
Moreover, expression of HVT levels in feathers with respect to SLV onset, revealed
heightened HVT levels 0.5 to 1 week before SLV onset. The increase in HVT DNA levels
may be due to viral replication. However, HVT gp expression could only be detected in
spleen from SL and controls but not in feather tips (Figure 8). It appears that increased
HVT load in the SL MCs environment just prior to visible onset of SLV may be a factor in
SLV development. The LCM study examining HVT viral load in certain areas within the
feather also revealed a stronger correlation of HVT viral load in the feather and the
MC-area in SLV and SLnoV chickens compared to that in BL (Figure 7), which also
supports this conclusion.

A role of the immune system has been well established in the autoimmune etiology of SLV
(Wick et al., 2006). Both humoral and cell-mediated immunity play a part in SLV
development and progression (Erf, 2008; Shi and Erf, 2012). In the current study, elevated
expression of IFN-γ, IL-8, IL-10, and IL-21 just prior to and during the active phase of SLV
strongly indicated immune response activation during the onset of vitiligo. Specifically,
IFN-γ plays an important role in macrophage activation, phagocytic activity, cytokine and
chemokine production, MHC I and MHC II expression (Abbas et al., 2010) and is the
signature cytokine of a Th1-polarized cell-mediated immune response. In addition to
driving cell-mediated immune activities, IFN-γ also has been shown to increase the
formation of autophagosomes in human CD4+ T cells (Son et al., 2010) and macrophages
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(Shi and Kehrl, 2010). The formation of autophagosomes in MCs from SLV chickens
(Boissy et al., 1983) has also been reported, which could be due to the heightened levels of
IFN-γ in the MC environment. Heightened proportions of MHC II-expressing cells in early
and active vitiligo samples (Shi and Erf, 2012; Erf et al., 1995) supports the role of IFN-γ
in antigen presentation and in macrophage, B-cell, and T-cell-activation. IL-8 is a
chemokine produced by macrophages during the inflammatory response (Abbas et al.,
2010). IL-8's primary function is to recruit phagocytic cells to the site of infection
(Mizunoe et al., 2012). The increased expression of IL-8 in SLV in this study is in support
of mononuclear cell infiltration observed during melanocyte loss. IL-10 is generally
known as a cytokine with anti-inflammatory and immune-suppressive activities (Abbas et
al., 2010). However, it also has been shown to have immunostimulatory effects by
increasing IFN-γ production and activation of natural killer cells and cytotoxic T cells (Tilg
et al., 2002). IL-10 and IFN-γ co-expression was also reported as a result of HVT infection
(Abdul-Careem et al., 2007) in feathers and HVT infection may have primed the
melanocyte-specific immune response in SLV in favor of immunostimulatory effects of
IL-10. Lastly, IL-21 has been shown to be required for sustainability of CD8+ T cells and
IFN-γ producing cells during chronic viral infection (Elsaesser et al., 2009). In addition,
the elevated gene expression of IL-10, IL-21, and IFN-γ at 3 weeks in SL feathers post
HVT administration at hatch (samples from previous study described in Study 3; data not
shown) may be a key connection of SLV with HVT. Taken together, the source of immune
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activation may be the routine vaccination at hatching with live HVT against
lymphoma-causing MDV which in SL may spiral out of control and focus on the stressed,
inherently fragile SL MC. The mechanisms underlying the interrelationship of cytokine
profile and HVT viral load in MC loss need to be further examined.
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Appendix 1. Time course of relative cytokines A) IL-1, B) IL-4, C) IL-8, D) IL-10, E) IL21,
F) IFN-gamma and G) tyrosinase (TYR) gene expression in the growing feather from HVT
vaccinated SLnoV, SLV, and BL chicks. One-day-old chicks from the vitiligo-prone SL,
parental BL chickens (N=10 and 4 per time point, respectively) were vaccinated with HVT
and feather samples were collected at 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, and 7.5 weeks
post-vaccination. Relative expression was calculated by the ΔΔC t method using a cDNA
pool made from 16 growing feather of BL chickens from each time point as the calibrator
and chicken 28S as the endogenous control gene. The X-axis represents the time (weeks) of
feather tip collection post HVT vaccination. The mean ± SEM of relative gene expression
averaged from each SLnoV, SLV, and BL chickens.
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Conclusion
The Smyth line (SL) chicken is an excellent animal model for human autoimmune
vitiligo. In addition to the spontaneous and predictably high incidence of vitiligo in the
SL chicken, the advantages of using the SL chicken model to study the etiology of vitiligo
include the location of melanocytes in growing feathers, providing repeated access to the
evolving autoimmune lesions in the same individual for in in vitro and/or in vivo studies.
Other advantages of the SL model include the regeneration characteristics of growing
feathers, the availability of pure melanocytes derived from growing feathers and 72 h
embryos, the identification of a reliable environmental trigger (herpesvirus of turkey; HVT)
of SL vitiligo expression, as well as, the MHC-matched control lines of chickens with low
or no expression of vitiligo. Results regarding the effects of 4-TBP induced oxidative stress
on the response of SL melanocytes, reinforces the concept of an inherent melanocyte defect
in SL chickens and also demonstrates the value and suitability of SL chicken as the avian
model for human autoimmune vitiligo. The observed progressive reduction (90 to 0%) in
HVT’s ability to trigger SL vitiligo during the first 10 weeks of age suggests that HVT
exerts its effect on vitiligo expression when adaptive immunity is not fully developed. The
observation of elevated cytokine expression (IL-8, IL-10, IFN-γ and IL-21) during active
SL vitiligo which was preceded by increased levels of HVT at 1 to 0.5 weeks before SL
vitiligo onset, strengthens the association of HVT-infection and development of the
melanocyte-specific autoimmune response. With the translocation of HVT to the feather,
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its presence and resulting immune activity may cause cellular stress in the inherently
defective SL melanocyte. Stress-associated melanocyte alterations may lead to immune
recognition of SL melanocytes and development of melanocyte-specific autoimmune
disease.
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